form_type
stringclasses 2
values | accession_number
stringlengths 20
20
| filing_date
stringlengths 14
14
| quarter_ending
stringclasses 172
values | company_name
stringlengths 5
54
| text
stringlengths 101
2.42k
| entities
listlengths 1
18
|
|---|---|---|---|---|---|---|
10-K | 0001628280-20-003693 | 20200317071246 | 20191231 | BAXTER INTERNATIONAL INC | The $5 million decrease to net income was driven by the items described above in the consolidated statement of income for the three months ended March 31, 2019 section. | [
{
"currency_/_unit": "USD",
"end_character": 6,
"end_date_for_period": "2019-03-31",
"label": "earnings",
"start_character": 5,
"start_date_for_period": "2019-01-01",
"value": -5000000
}
] |
10-K | 0001628280-20-003693 | 20200317071246 | 20191231 | BAXTER INTERNATIONAL INC | The $2 million decrease to net income was driven by the items described above in the consolidated statement of income for the three months ended June 30, 2018 section. | [
{
"currency_/_unit": "USD",
"end_character": 6,
"end_date_for_period": "2018-06-30",
"label": "earnings",
"start_character": 5,
"start_date_for_period": "2018-04-01",
"value": -2000000
}
] |
10-K | 0001628280-20-003693 | 20200317071246 | 20191231 | BAXTER INTERNATIONAL INC | The $9 million decrease to net income was driven by the items described above in the consolidated statement of income for the six months ended June 30, 2018 section. | [
{
"currency_/_unit": "USD",
"end_character": 6,
"end_date_for_period": "2018-06-30",
"label": "earnings",
"start_character": 5,
"start_date_for_period": "2018-01-01",
"value": -9000000
}
] |
10-K | 0001628280-20-003693 | 20200317071246 | 20191231 | BAXTER INTERNATIONAL INC | The $7 million decrease to net income was driven by the items described above in the consolidated statement of income for the three months ended March 31, 2018 section. | [
{
"currency_/_unit": "USD",
"end_character": 6,
"end_date_for_period": "2018-03-31",
"label": "earnings",
"start_character": 5,
"start_date_for_period": "2018-01-01",
"value": -7000000
}
] |
10-K | 0001628280-20-003693 | 20200317071246 | 20191231 | BAXTER INTERNATIONAL INC | The $35 million decrease to net income was driven by the items described above in the consolidated statement of income for the six months ended June 30, 2019 section. | [
{
"currency_/_unit": "USD",
"end_character": 7,
"end_date_for_period": "2019-06-30",
"label": "earnings",
"start_character": 5,
"start_date_for_period": "2019-01-01",
"value": -35000000
}
] |
10-K | 0001628280-20-003693 | 20200317071246 | 20191231 | BAXTER INTERNATIONAL INC | The $5 million decrease to net income was driven by the items described above in the consolidated statement of income for the three months ended March 31, 2019 section. | [
{
"currency_/_unit": "USD",
"end_character": 6,
"end_date_for_period": "2019-03-31",
"label": "earnings",
"start_character": 5,
"start_date_for_period": "2019-01-01",
"value": -5000000
}
] |
10-K | 0001628280-20-003693 | 20200317071246 | 20191231 | BAXTER INTERNATIONAL INC | The $9 million decrease to net income was driven by the items described above in the consolidated statement of income for the six months ended June 30, 2018 section. | [
{
"currency_/_unit": "USD",
"end_character": 6,
"end_date_for_period": "2018-06-30",
"label": "earnings",
"start_character": 5,
"start_date_for_period": "2018-01-01",
"value": -9000000
}
] |
10-K | 0001628280-20-003693 | 20200317071246 | 20191231 | BAXTER INTERNATIONAL INC | The $7 million decrease to net income was driven by the items described above in the consolidated statement of income for the three months ended March 31, 2018 section. | [
{
"currency_/_unit": "USD",
"end_character": 6,
"end_date_for_period": "2018-03-31",
"label": "earnings",
"start_character": 5,
"start_date_for_period": "2018-01-01",
"value": -7000000
}
] |
10-K | 0001628280-20-003880 | 20200320171217 | 20191231 | CUMBERLAND PHARMACEUTICALS INC | The Company has one operating segment which is specialty pharmaceutical products. Management has chosen to organize the Company based on the type of products sold. Operating segments are identified as components of an enterprise about which separate discrete financial information is evaluated by the chief operating decision maker, or decision-making group, in making decisions regarding resource allocation and assessing performance. The Company, which uses consolidated financial information in determining how to allocate resources and assess performance, evaluated that our specialty pharmaceutical products compete in similar economic markets and similar circumstances. Substantially all of the Company’s assets are located in the United States. Total revenues are primarily attributable to U.S. customers. Net revenues from customers outside the United States were approximately $1.5 million, $2.1 million and $1.6 million for the years ended December 31, 2019, 2018 and 2017, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 892,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 889,
"start_date_for_period": "2019-01-01",
"value": 1500000
},
{
"currency_/_unit": "USD",
"end_character": 906,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 903,
"start_date_for_period": "2018-01-01",
"value": 2100000
},
{
"currency_/_unit": "USD",
"end_character": 923,
"end_date_for_period": "2017-12-31",
"label": "revenues",
"start_character": 920,
"start_date_for_period": "2017-01-01",
"value": 1600000
}
] |
10-K | 0001628280-20-004221 | 20200327160320 | 20191231 | Ocugen, Inc. | The Company has incurred recurring losses and negative cash flows from operations since inception and has funded its operating losses through the sale of common stock, warrants to purchase common stock, the issuance of convertible notes, and debt. The Company incurred net losses of approximately $20.2 million and $18.2 million for the year ended December 31, 2019 and 2018, respectively, and had an accumulated deficit of $51.5 million as of December 31, 2019. As of December 31, 2019, the Company had cash, cash equivalents and restricted cash totaling $7.6 million. | [
{
"currency_/_unit": "USD",
"end_character": 302,
"end_date_for_period": "2019-12-31",
"label": "earnings",
"start_character": 298,
"start_date_for_period": "2019-01-01",
"value": -20200000
},
{
"currency_/_unit": "USD",
"end_character": 320,
"end_date_for_period": "2018-12-31",
"label": "earnings",
"start_character": 316,
"start_date_for_period": "2018-01-01",
"value": -18200000
},
{
"currency_/_unit": "USD",
"end_character": 429,
"end_date_for_period": "2019-12-31",
"label": "XBRL-OOS",
"start_character": 425,
"start_date_for_period": "2019-12-31",
"value": 51500000
},
{
"currency_/_unit": "USD",
"end_character": 560,
"end_date_for_period": "2019-12-31",
"label": "XBRL-OOS",
"start_character": 557,
"start_date_for_period": "2019-12-31",
"value": 7600000
}
] |
10-K | 0001628280-20-004377 | 20200330171020 | 20191231 | Phunware, Inc. | For the years ended December 31, 2019 and 2018, the Company had net losses before income taxes of $12,866 and $10,177, respectively. Net losses relating to U.S. operations for were $12,766 and $9,880, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 105,
"end_date_for_period": "2019-12-31",
"label": "earnings",
"start_character": 99,
"start_date_for_period": "2019-01-01",
"value": -12866000
},
{
"currency_/_unit": "USD",
"end_character": 117,
"end_date_for_period": "2018-12-31",
"label": "earnings",
"start_character": 111,
"start_date_for_period": "2018-01-01",
"value": -10177000
},
{
"currency_/_unit": "USD",
"end_character": 188,
"end_date_for_period": "2019-12-31",
"label": "earnings",
"start_character": 182,
"start_date_for_period": "2019-01-01",
"value": -12766000
},
{
"currency_/_unit": "USD",
"end_character": 199,
"end_date_for_period": "2018-12-31",
"label": "earnings",
"start_character": 194,
"start_date_for_period": "2018-01-01",
"value": -9880000
}
] |
10-K | 0001633070-20-000012 | 20200323161204 | 20191231 | Axcella Health Inc. | The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the ordinary course of business. Through December 31, 2019, the Company has funded its operations primarily with proceeds from the sale of preferred stock, borrowings under a loan and security agreement and the sale of common stock in the Company’s initial public offering (“IPO”), which was completed on May 8, 2019. The Company has incurred recurring losses since its inception, including net losses of $59.0 million and $36.1 million for the years ended December 31, 2019 and 2018, respectively. In addition, as of December 31, 2019, the Company had an accumulated deficit of $216.1 million. The Company expects to continue to generate operating losses for the foreseeable future. The future viability of the Company is dependent on its ability to raise additional capital to finance its operations. The Company’s inability to raise capital as and when needed could have a negative impact on its financial condition and ability to pursue its business strategies. There can be no assurance that the current operating plan will be achieved or that additional funding will be available on terms acceptable to the Company, or at all. The Company believes the cash and cash equivalents on hand as of December 31, 2019 of $92.1 million will be sufficient to fund its operations and capital expenditure requirements through at least the next twelve months following the issuance date of the financial statements. | [
{
"currency_/_unit": "USD",
"end_character": 606,
"end_date_for_period": "2017-12-31",
"label": "earnings",
"start_character": 602,
"start_date_for_period": "2017-01-01",
"value": -59000000
},
{
"currency_/_unit": "USD",
"end_character": 624,
"end_date_for_period": "2018-12-31",
"label": "earnings",
"start_character": 620,
"start_date_for_period": "2018-01-01",
"value": -36100000
},
{
"currency_/_unit": "USD",
"end_character": 781,
"end_date_for_period": "2019-12-31",
"label": "XBRL-OOS",
"start_character": 776,
"start_date_for_period": "2019-12-31",
"value": -216100000
},
{
"currency_/_unit": "USD",
"end_character": 1420,
"end_date_for_period": "2019-12-31",
"label": "XBRL-OOS",
"start_character": 1416,
"start_date_for_period": "2019-12-31",
"value": 92100000
}
] |
10-K | 0001635282-20-000014 | 20200316160653 | 20191231 | Rimini Street, Inc. | The ASC 606 adjustments for the first quarter of 2019 were as follows: a reduction in revenue of $0.4 million, an increase in sales and marketing expenses of $0.6 million and an increase in general administrative expenses of $0.6 million, resulting in a net loss adjustment of $1.5 million. | [
{
"currency_/_unit": "USD",
"end_character": 101,
"end_date_for_period": "2019-03-31",
"label": "revenues",
"start_character": 98,
"start_date_for_period": "2019-01-01",
"value": -400000
},
{
"currency_/_unit": "USD",
"end_character": 162,
"end_date_for_period": "2019-03-31",
"label": "XBRL-OOS",
"start_character": 159,
"start_date_for_period": "2019-01-01",
"value": 600000
},
{
"currency_/_unit": "USD",
"end_character": 229,
"end_date_for_period": "2019-03-31",
"label": "XBRL-OOS",
"start_character": 226,
"start_date_for_period": "2019-01-01",
"value": 600000
},
{
"currency_/_unit": "USD",
"end_character": 281,
"end_date_for_period": "2019-03-31",
"label": "earnings",
"start_character": 278,
"start_date_for_period": "2019-01-01",
"value": -1500000
}
] |
10-K | 0001635282-20-000014 | 20200316160653 | 20191231 | Rimini Street, Inc. | The ASC 606 adjustments for the second quarter of 2019 were as follows: an increase in revenue of $1.9 million, an increase in sales and marketing expenses of $0.6 million and a reduction in general and administrative expenses of $0.6 million, resulting in net income adjustment of $2.0 million. | [
{
"currency_/_unit": "USD",
"end_character": 102,
"end_date_for_period": "2019-06-30",
"label": "revenues",
"start_character": 99,
"start_date_for_period": "2019-04-01",
"value": 1900000
},
{
"currency_/_unit": "USD",
"end_character": 163,
"end_date_for_period": "2019-06-30",
"label": "XBRL-OOS",
"start_character": 160,
"start_date_for_period": "2019-04-01",
"value": 600000
},
{
"currency_/_unit": "USD",
"end_character": 234,
"end_date_for_period": "2019-06-30",
"label": "XBRL-OOS",
"start_character": 231,
"start_date_for_period": "2019-04-01",
"value": 600000
},
{
"currency_/_unit": "USD",
"end_character": 286,
"end_date_for_period": "2019-06-30",
"label": "earnings",
"start_character": 283,
"start_date_for_period": "2019-04-01",
"value": 2000000
}
] |
10-K | 0001635282-20-000014 | 20200316160653 | 20191231 | Rimini Street, Inc. | The ASC 606 adjustments for the third quarter of 2019 were as follows: an increase in revenue of $0.2 million, an increase of sales and marketing of $40,000 and an increase in general and administrative expenses of $0.6 million, resulting in net loss adjustment of $0.4 million. | [
{
"currency_/_unit": "USD",
"end_character": 101,
"end_date_for_period": "2019-09-30",
"label": "revenues",
"start_character": 98,
"start_date_for_period": "2019-07-01",
"value": 200000
},
{
"currency_/_unit": "USD",
"end_character": 156,
"end_date_for_period": "2019-09-30",
"label": "XBRL-OOS",
"start_character": 150,
"start_date_for_period": "2019-07-01",
"value": 40000
},
{
"currency_/_unit": "USD",
"end_character": 219,
"end_date_for_period": "2019-09-30",
"label": "XBRL-OOS",
"start_character": 216,
"start_date_for_period": "2019-07-01",
"value": 600000
},
{
"currency_/_unit": "USD",
"end_character": 269,
"end_date_for_period": "2019-09-30",
"label": "earnings",
"start_character": 266,
"start_date_for_period": "2019-07-01",
"value": -400000
}
] |
10-K | 0001635282-20-000014 | 20200316160653 | 20191231 | Rimini Street, Inc. | The ASC 606 adjustments for the first quarter of 2018 were as follows: a reduction in revenue of $1.3 million, a reduction in sales and marketing of $21,000 and an increase in other expenses of $1,000, resulting in a net loss adjustment of $1.3 million. | [
{
"currency_/_unit": "USD",
"end_character": 101,
"end_date_for_period": "2018-03-31",
"label": "revenues",
"start_character": 98,
"start_date_for_period": "2018-01-01",
"value": -1300000
},
{
"currency_/_unit": "USD",
"end_character": 156,
"end_date_for_period": "2018-03-31",
"label": "XBRL-OOS",
"start_character": 150,
"start_date_for_period": "2018-01-01",
"value": -21000
},
{
"currency_/_unit": "USD",
"end_character": 200,
"end_date_for_period": "2018-03-31",
"label": "XBRL-OOS",
"start_character": 195,
"start_date_for_period": "2018-01-01",
"value": -1000
},
{
"currency_/_unit": "USD",
"end_character": 244,
"end_date_for_period": "2018-03-31",
"label": "revenues",
"start_character": 241,
"start_date_for_period": "2018-01-01",
"value": -1300000
}
] |
10-K | 0001635282-20-000014 | 20200316160653 | 20191231 | Rimini Street, Inc. | The ASC 606 adjustments for the second quarter of 2018 were as follows: an increase in revenue of $0.7 million, a reduction of sales and marketing of $0.4 million and an increase in other expense of $0.1 million, resulting in net income adjustment of $1.0 million. | [
{
"currency_/_unit": "USD",
"end_character": 102,
"end_date_for_period": "2018-06-30",
"label": "revenues",
"start_character": 99,
"start_date_for_period": "2018-04-01",
"value": 700000
},
{
"currency_/_unit": "USD",
"end_character": 154,
"end_date_for_period": "2018-06-30",
"label": "XBRL-OOS",
"start_character": 151,
"start_date_for_period": "2018-04-01",
"value": -400000
},
{
"currency_/_unit": "USD",
"end_character": 203,
"end_date_for_period": "2018-06-30",
"label": "XBRL-OOS",
"start_character": 200,
"start_date_for_period": "2018-04-01",
"value": -100000
},
{
"currency_/_unit": "USD",
"end_character": 255,
"end_date_for_period": "2018-06-30",
"label": "earnings",
"start_character": 252,
"start_date_for_period": "2018-04-01",
"value": 1000000
}
] |
10-K | 0001635282-20-000014 | 20200316160653 | 20191231 | Rimini Street, Inc. | The ASC 606 adjustments for the third quarter of 2018 were as follows: an increase in revenue of $0.8 million, a reduction of sales and marketing expenses of $0.5 million and an increase in other expenses of $0.1 million, resulting in a net income adjustment of $1.2 million. | [
{
"currency_/_unit": "USD",
"end_character": 101,
"end_date_for_period": "2018-09-30",
"label": "revenues",
"start_character": 98,
"start_date_for_period": "2018-07-01",
"value": 800000
},
{
"currency_/_unit": "USD",
"end_character": 162,
"end_date_for_period": "2018-09-30",
"label": "XBRL-OOS",
"start_character": 159,
"start_date_for_period": "2018-07-01",
"value": -500000
},
{
"currency_/_unit": "USD",
"end_character": 212,
"end_date_for_period": "2018-09-30",
"label": "XBRL-OOS",
"start_character": 209,
"start_date_for_period": "2018-07-01",
"value": -100000
},
{
"currency_/_unit": "USD",
"end_character": 266,
"end_date_for_period": "2018-09-30",
"label": "earnings",
"start_character": 263,
"start_date_for_period": "2018-07-01",
"value": 1200000
}
] |
10-K | 0001645113-20-000025 | 20200227065320 | 20191231 | NovoCure Ltd | In the first quarter of 2018, the Company made the final milestone payment of $5.5 million (the "Milestone Payment") to the Technion Research and Development Foundation ("Technion") pursuant to the settlement agreement dated February 10, 2015 (the "Settlement Agreement"). Pursuant to the Settlement Agreement, and in exchange for a release of potential disputes regarding intellectual property developed by our founder and previously assigned to us, the Company was obligated to pay the Milestone Payment to Technion in the quarter following the quarter in which the Company achieved $250.0 million of cumulative net sales (as defined in the Settlement Agreement) (the "Net Sales Milestone"). The Company met the Net Sales Milestone in the fourth quarter of 2017. | [
{
"currency_/_unit": "USD",
"end_character": 82,
"end_date_for_period": "2018-03-31",
"label": "XBRL-OOS",
"start_character": 79,
"start_date_for_period": "2018-01-01",
"value": 5500000
},
{
"currency_/_unit": "USD",
"end_character": 591,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 586,
"start_date_for_period": "2018-01-01",
"value": 250000000
}
] |
10-K | 0001647088-20-000010 | 20200302102500 | 20191231 | WillScot Corp | (c) Historical Acton revenues were $93.9 million and historical ModSpace revenues were $443.5 million, respectively, for the year ended December 31, 2017. Historical Acton pre-tax loss was $3.2 million and historical ModSpace pre-tax loss was $108.1 million, respectively, for the year ended December 31, 2017. | [
{
"currency_/_unit": "USD",
"end_character": 40,
"end_date_for_period": "2017-12-31",
"label": "revenues",
"start_character": 36,
"start_date_for_period": "2017-01-01",
"value": 93900000
},
{
"currency_/_unit": "USD",
"end_character": 93,
"end_date_for_period": "2017-12-31",
"label": "revenues",
"start_character": 88,
"start_date_for_period": "2017-01-01",
"value": 443500000
},
{
"currency_/_unit": "USD",
"end_character": 193,
"end_date_for_period": "2017-12-31",
"label": "earnings",
"start_character": 190,
"start_date_for_period": "2017-01-01",
"value": 3200000
},
{
"currency_/_unit": "USD",
"end_character": 249,
"end_date_for_period": "2017-12-31",
"label": "earnings",
"start_character": 244,
"start_date_for_period": "2017-01-01",
"value": 108100000
}
] |
10-K | 0001654151-20-000003 | 20200309160832 | 20191231 | Deciphera Pharmaceuticals, Inc. | The accompanying consolidated financial statements have been prepared on the basis of continuity of operations, realization of assets and the satisfaction of liabilities, and commitments in the ordinary course of business. Since inception, the Company has incurred recurring losses including net losses of $192.3 million, $99.9 million, and $50.3 million for the years ended December 31, 2019, 2018, and 2017, respectively. As of December 31, 2019, the Company had an accumulated deficit of $488.0 million. The Company expects to continue to generate operating losses in the foreseeable future. The Company expects that its cash, cash equivalents, and marketable securities of $579.6 million as of December 31, 2019, together with the proceeds from the recent follow-on offering of common stock in February 2020, will be sufficient to fund its operating expenses and capital expenditure requirements through at least 12 months from the issuance date of these consolidated financial statements. The future viability of the Company is dependent on its ability to raise additional capital to fund its operations. | [
{
"currency_/_unit": "USD",
"end_character": 312,
"end_date_for_period": "2019-12-31",
"label": "earnings",
"start_character": 307,
"start_date_for_period": "2019-01-01",
"value": -192300000
},
{
"currency_/_unit": "USD",
"end_character": 327,
"end_date_for_period": "2018-12-31",
"label": "earnings",
"start_character": 323,
"start_date_for_period": "2018-01-01",
"value": -99900000
},
{
"currency_/_unit": "USD",
"end_character": 346,
"end_date_for_period": "2017-12-31",
"label": "earnings",
"start_character": 342,
"start_date_for_period": "2017-01-01",
"value": -50300000
},
{
"currency_/_unit": "USD",
"end_character": 497,
"end_date_for_period": "2019-12-31",
"label": "XBRL-OOS",
"start_character": 492,
"start_date_for_period": "2019-12-31",
"value": -488000000
},
{
"currency_/_unit": "USD",
"end_character": 683,
"end_date_for_period": "2019-12-31",
"label": "XBRL-OOS",
"start_character": 678,
"start_date_for_period": "2019-12-31",
"value": 579600000
}
] |
10-K | 0001701541-20-000009 | 20200324074750 | 20191231 | Black Diamond Therapeutics, Inc. | The accompanying consolidated financial statements have been prepared on the basis of continuity of operations, realization of assets, and the satisfaction of liabilities and commitments in the ordinary course of business. From its inception through December 31, 2019, the Company has funded its operations primarily with proceeds from the sale of convertible preferred and common stock and borrowings under convertible promissory notes. The Company has incurred recurring losses since its inception, including net losses of $35,258 and $8,931 for the years ended December 31, 2019 and 2018, respectively. In addition, as of December 31, 2019 and 2018, the Company had an accumulated deficit of $50,970 and $15,712, respectively. The Company expects to continue to generate operating losses for the foreseeable future. | [
{
"currency_/_unit": "USD",
"end_character": 532,
"end_date_for_period": "2019-12-31",
"label": "earnings",
"start_character": 526,
"start_date_for_period": "2019-01-01",
"value": -35258000
},
{
"currency_/_unit": "USD",
"end_character": 543,
"end_date_for_period": "2018-12-31",
"label": "earnings",
"start_character": 538,
"start_date_for_period": "2018-01-01",
"value": -8931000
},
{
"currency_/_unit": "USD",
"end_character": 702,
"end_date_for_period": "2019-12-31",
"label": "XBRL-OOS",
"start_character": 696,
"start_date_for_period": "2019-12-31",
"value": -50970000
},
{
"currency_/_unit": "USD",
"end_character": 714,
"end_date_for_period": "2018-12-31",
"label": "XBRL-OOS",
"start_character": 708,
"start_date_for_period": "2018-12-31",
"value": -15712000
}
] |
10-K | 0001712923-20-000010 | 20200302161207 | 20191231 | GreenSky, Inc. | The Company's income before income tax expense of $88,848, $133,514 and $138,668 during the years ended December 31, 2019, 2018 and 2017, respectively, consisted entirely of income earned in the United States. | [
{
"currency_/_unit": "USD",
"end_character": 57,
"end_date_for_period": "2019-12-31",
"label": "earnings",
"start_character": 51,
"start_date_for_period": "2019-01-01",
"value": 88848000
},
{
"currency_/_unit": "USD",
"end_character": 67,
"end_date_for_period": "2018-12-31",
"label": "earnings",
"start_character": 60,
"start_date_for_period": "2018-01-01",
"value": 133514000
},
{
"currency_/_unit": "USD",
"end_character": 80,
"end_date_for_period": "2017-12-31",
"label": "earnings",
"start_character": 73,
"start_date_for_period": "2017-01-01",
"value": 138668000
}
] |
10-K | 0001720725-20-000006 | 20200227162115 | 20191231 | Oyster Point Pharma, Inc. | Since inception, the Company has incurred recurring losses and negative cash flows from operations. The Company incurred net losses of $45.7 million and $16.5 million for the years ended December 31, 2019 and 2018, respectively, and had an accumulated deficit of $84.2 million as of December 31, 2019. The Company has historically financed its operations primarily through the sale and issuance of its securities. To date, none of the Company’s product candidates have been approved for sale and therefore the Company has not generated any revenue from product sales. The Company expects to incur increased sales and marketing expenses with the commercialization of new and existing products, if approved for sale, as well as increased research and development expenses as it develops additional product candidates. The Company expects its operating losses to continue to increase for the foreseeable future. | [
{
"currency_/_unit": "USD",
"end_character": 140,
"end_date_for_period": "2019-12-31",
"label": "earnings",
"start_character": 136,
"start_date_for_period": "2019-01-01",
"value": -45700000
},
{
"currency_/_unit": "USD",
"end_character": 158,
"end_date_for_period": "2018-12-31",
"label": "earnings",
"start_character": 154,
"start_date_for_period": "2018-01-01",
"value": -16500000
},
{
"currency_/_unit": "USD",
"end_character": 268,
"end_date_for_period": "2019-12-31",
"label": "XBRL-OOS",
"start_character": 264,
"start_date_for_period": "2019-12-31",
"value": -84200000
}
] |
10-K | 0001733186-20-000032 | 20200221100240 | 20191231 | Veoneer, Inc. | During 2019 under the Company’s LTI program, certain non-employee directors received 39,886 RSUs with dividend equivalent rights. | [
{
"currency_/_unit": "shares",
"end_character": 91,
"end_date_for_period": "2019-12-31",
"label": "eps",
"start_character": 85,
"start_date_for_period": "2019-01-01",
"value": 39886
}
] |
10-K | 0001771515-20-000005 | 20200325165322 | 20191228 | Grocery Outlet Holding Corp. | Income before income taxes consisted entirely of income from domestic operations of $16.8 million, $21.9 million, and $25.8 million for the fiscal years ended December 28, 2019, December 29, 2018, and December 30, 2017, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 89,
"end_date_for_period": "2019-12-28",
"label": "earnings",
"start_character": 85,
"start_date_for_period": "2018-12-30",
"value": 16800000
},
{
"currency_/_unit": "USD",
"end_character": 104,
"end_date_for_period": "2018-12-29",
"label": "earnings",
"start_character": 100,
"start_date_for_period": "2017-12-31",
"value": 21900000
},
{
"currency_/_unit": "USD",
"end_character": 123,
"end_date_for_period": "2017-12-30",
"label": "earnings",
"start_character": 119,
"start_date_for_period": "2017-01-01",
"value": 25800000
}
] |
10-K | 0000353184-20-000035 | 20200626152247 | 20200331 | AIR T INC | The Company, under the terms of its overnight air cargo dry-lease service contracts, passes through to its air cargo customer certain cost components of its operations without markup. The cost of fuel, landing fees, outside maintenance, parts and certain other direct operating costs are included in operating expenses and billed to the customer, at cost, and included in overnight air cargo revenue on the accompanying statements of income. These pass-through costs totaled $23.7 million and $23.6 million for the years ended March 31, 2020 and 2019, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 480,
"end_date_for_period": "2020-03-31",
"label": "revenues",
"start_character": 476,
"start_date_for_period": "2019-04-01",
"value": 23700000
},
{
"currency_/_unit": "USD",
"end_character": 498,
"end_date_for_period": "2019-03-31",
"label": "revenues",
"start_character": 494,
"start_date_for_period": "2018-04-01",
"value": 23600000
}
] |
10-K | 0000353184-20-000035 | 20200626152247 | 20200331 | AIR T INC | Delphax’s components of net income (loss) are included in our consolidated statements of income and comprehensive income herein. For the years ended March 31, 2020 and 2019, Delphax did not recognize any revenue. For the year ended March 31, 2020, Delphax recorded net income of $6.1 million, broken out between an operating loss of $0.2 million and non-operating income of $6.3 million, the majority of which was the result of the gain on dissolution of entities of $4.5 million. For the year ended March 31, 2019, Delphax recorded net loss of $0.5 million, broken out between an operating loss of $0.3 million and non-operating expense of $0.2 million. | [
{
"currency_/_unit": "USD",
"end_character": 283,
"end_date_for_period": "2020-03-31",
"label": "XBRL-OOS",
"start_character": 280,
"start_date_for_period": "2019-04-01",
"value": 6100000
},
{
"currency_/_unit": "USD",
"end_character": 337,
"end_date_for_period": "2020-03-31",
"label": "ebit",
"start_character": 334,
"start_date_for_period": "2019-04-01",
"value": -200000
},
{
"currency_/_unit": "USD",
"end_character": 378,
"end_date_for_period": "2020-03-31",
"label": "XBRL-OOS",
"start_character": 375,
"start_date_for_period": "2019-04-01",
"value": 6300000
},
{
"currency_/_unit": "USD",
"end_character": 549,
"end_date_for_period": "2019-03-31",
"label": "XBRL-OOS",
"start_character": 546,
"start_date_for_period": "2018-04-01",
"value": -500000
},
{
"currency_/_unit": "USD",
"end_character": 603,
"end_date_for_period": "2019-03-31",
"label": "ebit",
"start_character": 600,
"start_date_for_period": "2018-04-01",
"value": -300000
},
{
"currency_/_unit": "USD",
"end_character": 645,
"end_date_for_period": "2020-03-31",
"label": "ebit",
"start_character": 642,
"start_date_for_period": "2019-04-01",
"value": -200000
}
] |
10-K | 0001017480-20-000010 | 20200416172147 | 20200201 | HIBBETT SPORTS INC | We excluded 31,050 non-vested stock awards granted to certain employees from the computation of diluted weighted average common shares and common share equivalents outstanding, because they are subject to performance-based annual vesting conditions which had not been achieved by the end of Fiscal 2020. Assuming the performance criteria had been achieved at target as of February 1, 2020, the incremental dilutive impact would have been 19,998 shares. | [
{
"currency_/_unit": "shares",
"end_character": 18,
"end_date_for_period": "2020-02-01",
"label": "XBRL-OOS",
"start_character": 12,
"start_date_for_period": "2019-02-03",
"value": 31050
},
{
"currency_/_unit": "shares",
"end_character": 445,
"end_date_for_period": "2020-02-01",
"label": "eps",
"start_character": 439,
"start_date_for_period": "2019-02-03",
"value": 19998
}
] |
10-K | 0001213900-20-013096 | 20200520161642 | 20200328 | RBC Bearings INC | Assets
and liabilities of the Company’s foreign operations are translated into U.S. dollars using the exchange rate in effect at the
balance sheet date. Results of operations are translated using the average exchange rate prevailing throughout the period. The
effects of exchange rate fluctuations on translating foreign currency assets and liabilities into U.S. dollars are included in
accumulated other comprehensive income (loss), while gains and losses resulting from foreign currency transactions are included
in other non-operating expense (income). Net income of the Company’s foreign operations for fiscal 2020, 2019 and 2018 amounted
to $3,526, $7,180 and $776, respectively. Total assets of the Company’s foreign operations were $159,039 and $115,789 at March
28, 2020 and March 30, 2019, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 652,
"end_date_for_period": "2020-03-28",
"label": "earnings",
"start_character": 647,
"start_date_for_period": "2019-03-31",
"value": 3526000
},
{
"currency_/_unit": "USD",
"end_character": 660,
"end_date_for_period": "2019-03-30",
"label": "earnings",
"start_character": 655,
"start_date_for_period": "2018-04-01",
"value": 7180000
},
{
"currency_/_unit": "USD",
"end_character": 669,
"end_date_for_period": "2018-03-31",
"label": "earnings",
"start_character": 666,
"start_date_for_period": "2017-04-01",
"value": 776000
},
{
"currency_/_unit": "USD",
"end_character": 747,
"end_date_for_period": "2020-03-28",
"label": "XBRL-OOS",
"start_character": 740,
"start_date_for_period": "2020-03-28",
"value": 159039000
},
{
"currency_/_unit": "USD",
"end_character": 760,
"end_date_for_period": "2019-03-30",
"label": "XBRL-OOS",
"start_character": 753,
"start_date_for_period": "2019-03-30",
"value": 115789000
}
] |
10-K | 0001628280-20-004877 | 20200413061100 | 20191231 | Teligent, Inc. | For the year ended December 31, 2019, domestic net revenues were $48.4 million and foreign net revenues were $17.5 million. As of December 31, 2019, domestic assets were $154.3 million and foreign assets were $52.6 million. For the year ended December 31, 2018, domestic net revenues were $45.6 million and foreign net revenues were $20.2 million. As of December 31, 2018, domestic assets were $132.7 million and foreign assets were $58.2 million. | [
{
"currency_/_unit": "USD",
"end_character": 70,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 66,
"start_date_for_period": "2019-01-01",
"value": 48400000
},
{
"currency_/_unit": "USD",
"end_character": 114,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 110,
"start_date_for_period": "2019-01-01",
"value": 17500000
},
{
"currency_/_unit": "USD",
"end_character": 176,
"end_date_for_period": "2019-12-31",
"label": "XBRL-OOS",
"start_character": 171,
"start_date_for_period": "2019-12-31",
"value": 154300000
},
{
"currency_/_unit": "USD",
"end_character": 214,
"end_date_for_period": "2019-12-31",
"label": "XBRL-OOS",
"start_character": 210,
"start_date_for_period": "2019-12-31",
"value": 52600000
},
{
"currency_/_unit": "USD",
"end_character": 294,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 290,
"start_date_for_period": "2018-01-01",
"value": 45600000
},
{
"currency_/_unit": "USD",
"end_character": 338,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 334,
"start_date_for_period": "2018-01-01",
"value": 20200000
},
{
"currency_/_unit": "USD",
"end_character": 400,
"end_date_for_period": "2018-12-31",
"label": "XBRL-OOS",
"start_character": 395,
"start_date_for_period": "2018-12-31",
"value": 132699999.99999999
},
{
"currency_/_unit": "USD",
"end_character": 438,
"end_date_for_period": "2018-12-31",
"label": "XBRL-OOS",
"start_character": 434,
"start_date_for_period": "2018-12-31",
"value": 58200000
}
] |
10-K | 0001654948-20-000021 | 20200429194309 | 20191231 | Hartman vREIT XXI, Inc. | For the years ended December 31, 2019 and 2018, the Company incurred a net loss of $1,084,902 and $1,292,229, respectively. The Company does not anticipate forming any taxable REIT subsidiaries or otherwise generating future taxable income which may be offset by the net loss carry forward. The Company considers that any deferred tax benefit and corresponding deferred tax asset which may be recorded in light of the net loss carry forward would be properly offset by an equal valuation allowance in that no future taxable income is expected. Accordingly, no deferred tax benefit or deferred tax asset has been recorded in the consolidated financial statements. | [
{
"currency_/_unit": "USD",
"end_character": 93,
"end_date_for_period": "2019-12-31",
"label": "earnings",
"start_character": 84,
"start_date_for_period": "2019-01-01",
"value": -1084902
},
{
"currency_/_unit": "USD",
"end_character": 108,
"end_date_for_period": "2018-12-31",
"label": "earnings",
"start_character": 99,
"start_date_for_period": "2018-01-01",
"value": -1292229
}
] |
10-K | 0001735828-20-000006 | 20200429184143 | 20191231 | Legacy Reserves Inc. | For the period of December 11, 2019 through December 31, 2019 (Successor), the period of January 1, 2019 through December 10, 2019 (Predecessor), the years ended December 31, 2018, and 2017 (Predecessor), we recorded income/(loss) before income taxes of $3.1 million, $174.0 million, $46.8 million and $(52.5) million, respectively. All of Legacy's income is sourced within the United States. | [
{
"currency_/_unit": "USD",
"end_character": 258,
"end_date_for_period": "2019-12-31",
"label": "earnings",
"start_character": 255,
"start_date_for_period": "2019-12-11",
"value": 3100000
},
{
"currency_/_unit": "USD",
"end_character": 274,
"end_date_for_period": "2019-12-10",
"label": "earnings",
"start_character": 269,
"start_date_for_period": "2019-01-01",
"value": 174000000
},
{
"currency_/_unit": "USD",
"end_character": 289,
"end_date_for_period": "2018-12-31",
"label": "earnings",
"start_character": 285,
"start_date_for_period": "2018-01-01",
"value": 46800000
},
{
"currency_/_unit": "USD",
"end_character": 308,
"end_date_for_period": "2017-12-31",
"label": "earnings",
"start_character": 304,
"start_date_for_period": "2017-01-01",
"value": -52500000
}
] |
10-K | 0000016732-20-000111 | 20200924074714 | 20200802 | CAMPBELL SOUP CO | In 2019, the acquisition of Snyder's-Lance contributed $2,192 to Net sales. The contribution to Earnings from continuing operations was a loss of $36 including expenses associated with restructuring charges and cost savings initiatives, as well as interest expense on the debt to finance the acquisition. | [
{
"currency_/_unit": "USD",
"end_character": 61,
"end_date_for_period": "2019-07-28",
"label": "revenues",
"start_character": 56,
"start_date_for_period": "2018-07-30",
"value": 2192000000
},
{
"currency_/_unit": "USD",
"end_character": 149,
"end_date_for_period": "2019-07-28",
"label": "XBRL-OOS",
"start_character": 147,
"start_date_for_period": "2018-07-30",
"value": -36000000
}
] |
10-K | 0000023197-20-000127 | 20200929160814 | 20200731 | COMTECH TELECOMMUNICATIONS CORP /DE/ | Sales to U.S. government customers include sales to the U.S. Department of Defense ("DoD"), intelligence and civilian agencies, as well as sales directly to or through prime contractors. Domestic sales include sales to commercial customers, as well as to U.S. state and local governments. Included in domestic sales are sales to Verizon Communications Inc. ("Verizon"). Sales to Verizon were 10.0% of consolidated net sales for fiscal 2018. Except for the U.S. government, there were no customers that represented more than 10.0% of consolidated net sales during fiscal 2020 and 2019. International sales for fiscal 2020, 2019 and 2018 (which include sales to U.S. domestic companies for inclusion in products that are sold to international customers) were $145,107,000, $170,607,000 and $145,784,000, respectively. Except for the U.S., no individual country (including sales to U.S. domestic companies for inclusion in products that are sold to a foreign country) represented more than 10.0% of consolidated net sales for fiscal 2020, 2019 and 2018. | [
{
"currency_/_unit": "pure",
"end_character": 396,
"end_date_for_period": "2018-07-31",
"label": "XBRL-OOS",
"start_character": 392,
"start_date_for_period": "2017-08-01",
"value": 0.1
},
{
"currency_/_unit": "USD",
"end_character": 769,
"end_date_for_period": "2020-07-31",
"label": "revenues",
"start_character": 758,
"start_date_for_period": "2019-08-01",
"value": 145107000
},
{
"currency_/_unit": "USD",
"end_character": 783,
"end_date_for_period": "2019-07-31",
"label": "revenues",
"start_character": 772,
"start_date_for_period": "2018-08-01",
"value": 170607000
},
{
"currency_/_unit": "USD",
"end_character": 800,
"end_date_for_period": "2018-07-31",
"label": "revenues",
"start_character": 789,
"start_date_for_period": "2017-08-01",
"value": 145784000
},
{
"currency_/_unit": "pure",
"end_character": 991,
"end_date_for_period": "2018-07-31",
"label": "XBRL-OOS",
"start_character": 987,
"start_date_for_period": "2017-08-01",
"value": 0.1
}
] |
10-K | 0000023197-20-000127 | 20200929160814 | 20200731 | COMTECH TELECOMMUNICATIONS CORP /DE/ | Our EPS calculations exclude 201,000, 243,000 and 258,000 weighted average performance shares outstanding for fiscal 2020, 2019 and 2018, respectively, as the performance conditions have not yet been satisfied. However, net income (the numerator) for EPS calculations for each respective period, is reduced by the compensation expense related to these awards. | [
{
"currency_/_unit": "shares",
"end_character": 36,
"end_date_for_period": "2020-07-31",
"label": "eps",
"start_character": 29,
"start_date_for_period": "2019-08-01",
"value": 201000
},
{
"currency_/_unit": "shares",
"end_character": 45,
"end_date_for_period": "2019-07-31",
"label": "eps",
"start_character": 38,
"start_date_for_period": "2018-08-01",
"value": 243000
},
{
"currency_/_unit": "shares",
"end_character": 57,
"end_date_for_period": "2018-07-31",
"label": "eps",
"start_character": 50,
"start_date_for_period": "2017-08-01",
"value": 258000
}
] |
10-K | 0000023197-20-000127 | 20200929160814 | 20200731 | COMTECH TELECOMMUNICATIONS CORP /DE/ | Intersegment sales in fiscal 2020, 2019 and 2018 by the Commercial Solutions segment to the Government Solutions segment were $9,837,000, $17,371,000 and $9,630,000, respectively. There were nominal sales by the Government Solutions segment to the Commercial Solutions segment for these fiscal periods. All intersegment sales are eliminated in consolidation and are excluded from the tables above. | [
{
"currency_/_unit": "USD",
"end_character": 136,
"end_date_for_period": "2020-07-31",
"label": "revenues",
"start_character": 127,
"start_date_for_period": "2019-08-01",
"value": 9837000
},
{
"currency_/_unit": "USD",
"end_character": 149,
"end_date_for_period": "2019-07-31",
"label": "revenues",
"start_character": 139,
"start_date_for_period": "2018-08-01",
"value": 17371000
},
{
"currency_/_unit": "USD",
"end_character": 164,
"end_date_for_period": "2018-07-31",
"label": "revenues",
"start_character": 155,
"start_date_for_period": "2017-08-01",
"value": 9630000
}
] |
10-K | 0000719733-20-000061 | 20200911145053 | 20200627 | KEY TRONIC CORP | For the fiscal year ended June 29, 2019, the reported revenue and gross profit was approximately $464.0 million, and $34.6 million; respectively. This reflects the adoption of ASC 606 as revenue and gross profit would have been $10.3 million and $1.9 million less without ASC 606 adoption; respectively. This is primarily due to the change from 'point-in-time' to 'over-time' recognition as the standard requires. There was not a material tax impact for the twelve months ended June 29, 2019 from adopting ASC 606. | [
{
"currency_/_unit": "USD",
"end_character": 103,
"end_date_for_period": "2019-06-29",
"label": "revenues",
"start_character": 98,
"start_date_for_period": "2018-07-01",
"value": 464000000
},
{
"currency_/_unit": "USD",
"end_character": 122,
"end_date_for_period": "2019-06-29",
"label": "XBRL-OOS",
"start_character": 118,
"start_date_for_period": "2018-07-01",
"value": 34600000
},
{
"currency_/_unit": "USD",
"end_character": 233,
"end_date_for_period": "2019-06-29",
"label": "revenues",
"start_character": 229,
"start_date_for_period": "2018-07-01",
"value": 10300000
},
{
"currency_/_unit": "USD",
"end_character": 250,
"end_date_for_period": "2019-06-29",
"label": "XBRL-OOS",
"start_character": 247,
"start_date_for_period": "2018-07-01",
"value": 1900000
}
] |
10-K | 0000719733-20-000061 | 20200911145053 | 20200627 | KEY TRONIC CORP | Of the revenues for the years ended June 27, 2020, June 29, 2019, and June 30, 2018, EMS sales and services were $449.5 million, $463.9 million and $445.8 million, respectively. Keyboard sales for the years ended June 27, 2020, June 29, 2019, and June 30, 2018 were $4,000, $0.1 million and $0.5 million, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 119,
"end_date_for_period": "2020-06-27",
"label": "revenues",
"start_character": 114,
"start_date_for_period": "2019-06-30",
"value": 449500000
},
{
"currency_/_unit": "USD",
"end_character": 135,
"end_date_for_period": "2019-06-29",
"label": "revenues",
"start_character": 130,
"start_date_for_period": "2018-07-01",
"value": 463900000
},
{
"currency_/_unit": "USD",
"end_character": 154,
"end_date_for_period": "2018-06-30",
"label": "revenues",
"start_character": 149,
"start_date_for_period": "2017-07-02",
"value": 445800000
},
{
"currency_/_unit": "USD",
"end_character": 272,
"end_date_for_period": "2020-06-27",
"label": "revenues",
"start_character": 267,
"start_date_for_period": "2019-06-30",
"value": 4000
},
{
"currency_/_unit": "USD",
"end_character": 278,
"end_date_for_period": "2019-06-29",
"label": "revenues",
"start_character": 275,
"start_date_for_period": "2018-07-01",
"value": 100000
},
{
"currency_/_unit": "USD",
"end_character": 295,
"end_date_for_period": "2018-06-30",
"label": "revenues",
"start_character": 292,
"start_date_for_period": "2017-07-02",
"value": 500000
}
] |
10-K | 0001137789-20-000057 | 20200807173950 | 20200703 | Seagate Technology plc | In accordance with its policy, the Company reviews the estimated useful lives of its fixed assets on an ongoing basis. This review indicated that the actual lives of certain manufacturing equipment at its manufacturing facilities were longer than the estimated useful lives used for depreciation purposes in the Company’s consolidated financial statements. As a result, effective June 29, 2019, the Company changed its estimate of the useful lives of its manufacturing equipment from a range of three to five years to a range of three to seven years. The effect of this change in estimate increased the net income by $134 million for the fiscal year ended July 3, 2020 and increased the diluted earnings per share by $0.51 for the fiscal year ended July 3, 2020 | [
{
"currency_/_unit": "USD",
"end_character": 621,
"end_date_for_period": "2020-07-03",
"label": "earnings",
"start_character": 618,
"start_date_for_period": "2019-06-29",
"value": 134000000
},
{
"currency_/_unit": null,
"end_character": 722,
"end_date_for_period": "2020-07-03",
"label": "XBRL-OOS",
"start_character": 718,
"start_date_for_period": "2019-06-29",
"value": 0.51
}
] |
10-K | 0001487198-20-000010 | 20200707163214 | 20200430 | ASPEN GROUP, INC. | The COVID-19 crisis did not have a material impact on the Company’s financial results for the fourth quarter of fiscal year 2020, as evidenced by our record revenues of $14,079,193. Course starts and persistence amongst our active student body remained at pre-COVID-19 levels throughout the fourth quarter of fiscal year 2020 and during May and June, 2020. | [
{
"currency_/_unit": "USD",
"end_character": 180,
"end_date_for_period": "2020-04-30",
"label": "revenues",
"start_character": 170,
"start_date_for_period": "2020-02-01",
"value": 14079193
}
] |
10-K | 0001530721-20-000062 | 20200708161859 | 20200328 | Capri Holdings Ltd | Versace’s results of operations have been included in our consolidated financial statements beginning on December 31, 2018. Versace contributed total revenue of $137 million and net loss of $12 million, after amortization of non-cash purchase accounting adjustments and transition and transaction costs, from the date of acquisition on December 31, 2018 through February 28, 2019 (reflecting a one-month reporting lag). | [
{
"currency_/_unit": "USD",
"end_character": 165,
"end_date_for_period": "2019-02-28",
"label": "XBRL-OOS",
"start_character": 162,
"start_date_for_period": "2018-12-31",
"value": 137000000
},
{
"currency_/_unit": "USD",
"end_character": 193,
"end_date_for_period": "2019-02-28",
"label": "earnings",
"start_character": 191,
"start_date_for_period": "2018-12-31",
"value": 12000000
}
] |
10-K | 0001530721-20-000062 | 20200708161859 | 20200328 | Capri Holdings Ltd | Jimmy Choo’s results of operations have been included in our consolidated financial statements beginning on November 1, 2017. Jimmy Choo contributed revenue of $223 million and net loss of $15 million (after amortization of non-cash purchase accounting adjustments and transition and transaction costs) for the period from the date of acquisition through March 31, 2018. | [
{
"currency_/_unit": "USD",
"end_character": 164,
"end_date_for_period": "2018-03-31",
"label": "XBRL-OOS",
"start_character": 161,
"start_date_for_period": "2017-11-01",
"value": 223000000
},
{
"currency_/_unit": "USD",
"end_character": 192,
"end_date_for_period": "2018-03-31",
"label": "earnings",
"start_character": 190,
"start_date_for_period": "2017-11-01",
"value": -15000000
}
] |
10-K | 0001564708-20-000022 | 20200811063722 | 20200630 | NEWS CORP | (Loss) income before income tax relating to News America Marketing included in the Statements of Operations was $(416) million, $22 million and $(100) million for the fiscal years ended June 30, 2020, 2019 and 2018, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 117,
"end_date_for_period": "2020-06-30",
"label": "earnings",
"start_character": 114,
"start_date_for_period": "2019-07-01",
"value": -416000000
},
{
"currency_/_unit": "USD",
"end_character": 131,
"end_date_for_period": "2019-06-30",
"label": "earnings",
"start_character": 129,
"start_date_for_period": "2018-07-01",
"value": 22000000
},
{
"currency_/_unit": "USD",
"end_character": 149,
"end_date_for_period": "2018-06-30",
"label": "earnings",
"start_character": 146,
"start_date_for_period": "2017-07-01",
"value": -100000000
}
] |
10-K | 0001564708-20-000022 | 20200811063722 | 20200630 | NEWS CORP | Revenues include approximately $3.7 billion for fiscal 2020, $3.9 billion for fiscal 2019 and $3.9 billion for fiscal 2018 from customers in the U.S. | [
{
"currency_/_unit": "USD",
"end_character": 35,
"end_date_for_period": "2020-06-30",
"label": "revenues",
"start_character": 32,
"start_date_for_period": "2019-07-01",
"value": 3700000000
},
{
"currency_/_unit": "USD",
"end_character": 65,
"end_date_for_period": "2019-06-30",
"label": "revenues",
"start_character": 62,
"start_date_for_period": "2018-07-01",
"value": 3900000000
},
{
"currency_/_unit": "USD",
"end_character": 98,
"end_date_for_period": "2019-06-30",
"label": "revenues",
"start_character": 95,
"start_date_for_period": "2018-07-01",
"value": 3900000000
}
] |
10-K | 0001564708-20-000022 | 20200811063722 | 20200630 | NEWS CORP | Revenues include approximately $1.2 billion for fiscal 2020, $1.3 billion for fiscal 2019 and $1.4 billion for fiscal 2018 from customers in the U.K. | [
{
"currency_/_unit": "USD",
"end_character": 35,
"end_date_for_period": "2020-06-30",
"label": "revenues",
"start_character": 32,
"start_date_for_period": "2019-07-01",
"value": 1200000000
},
{
"currency_/_unit": "USD",
"end_character": 65,
"end_date_for_period": "2019-06-30",
"label": "revenues",
"start_character": 62,
"start_date_for_period": "2018-07-01",
"value": 1300000000
},
{
"currency_/_unit": "USD",
"end_character": 98,
"end_date_for_period": "2018-06-30",
"label": "revenues",
"start_character": 95,
"start_date_for_period": "2017-07-01",
"value": 1400000000
}
] |
10-K | 0001564708-20-000022 | 20200811063722 | 20200630 | NEWS CORP | Revenues include approximately $3.5 billion for fiscal 2020, $4.0 billion for fiscal 2019 and $2.9 billion for fiscal 2018 from customers in Australia. | [
{
"currency_/_unit": "USD",
"end_character": 35,
"end_date_for_period": "2020-06-30",
"label": "revenues",
"start_character": 32,
"start_date_for_period": "2019-07-01",
"value": 3500000000
},
{
"currency_/_unit": "USD",
"end_character": 65,
"end_date_for_period": "2019-06-30",
"label": "revenues",
"start_character": 62,
"start_date_for_period": "2018-07-01",
"value": 4000000000
},
{
"currency_/_unit": "USD",
"end_character": 98,
"end_date_for_period": "2018-06-30",
"label": "revenues",
"start_character": 95,
"start_date_for_period": "2017-07-01",
"value": 2900000000
}
] |
10-K | 0001618732-20-000112 | 20200923163542 | 20200731 | Nutanix, Inc. | The 2023 Notes will have no impact to diluted earnings per share ("EPS") until they meet the criteria for conversion, as discussed above, as we intend to settle the principal amount of the 2023 Notes in cash upon conversion. Under the treasury stock method, in periods when we report net income, we are required to include the effect of additional shares that may be issued under the 2023 Notes when the price of our Class A common stock exceeds the conversion price. Under this method, the cumulative dilutive effect of the 2023 Notes would be approximately 3.9 million shares if the average price of our Class A common stock was $73.46. However, upon conversion, there will be no economic dilution from the 2023 Notes, as exercise of the note hedges eliminate any dilution that would have otherwise occurred. The note hedges are required to be excluded from the calculation of diluted earnings per share, as they would be antidilutive under the treasury stock method. | [
{
"currency_/_unit": "shares",
"end_character": 562,
"end_date_for_period": "2020-07-31",
"label": "eps",
"start_character": 559,
"start_date_for_period": "2019-08-01",
"value": 3900000
},
{
"currency_/_unit": null,
"end_character": 637,
"end_date_for_period": "2020-07-31",
"label": "XBRL-OOS",
"start_character": 632,
"start_date_for_period": "2020-07-31",
"value": 73.46
}
] |
10-K | 0000002969-20-000049 | 20201119152911 | 20200930 | AIR PRODUCTS & CHEMICALS INC /DE/ | Since our contracts are generally comprised of a single performance obligation, contract modifications are typically accounted for as part of the existing contract and are recognized as a cumulative adjustment for the inception-to-date effect of such change. In addition, changes in estimates on projects accounted for under the cost incurred input method are recognized as a cumulative adjustment for the inception-to-date effect of such change. Changes in estimates favorably impacted operating income by approximately $7, $37, and $38 in fiscal years 2020, 2019, and 2018, respectively. Our changes in estimates would not have significantly impacted amounts recorded in prior years. | [
{
"currency_/_unit": "USD",
"end_character": 523,
"end_date_for_period": "2020-09-30",
"label": "ebit",
"start_character": 522,
"start_date_for_period": "2019-10-01",
"value": 7000000
},
{
"currency_/_unit": "USD",
"end_character": 528,
"end_date_for_period": "2019-09-30",
"label": "ebit",
"start_character": 526,
"start_date_for_period": "2018-10-01",
"value": 37000000
},
{
"currency_/_unit": "USD",
"end_character": 537,
"end_date_for_period": "2018-09-30",
"label": "ebit",
"start_character": 535,
"start_date_for_period": "2017-10-01",
"value": 38000000
}
] |
10-K | 0000010795-20-000055 | 20201125142141 | 20200930 | BECTON DICKINSON & CO | The amounts in fiscal years 2019 and 2018 reflect the reclassification of U.S. revenues of $11 million and $17 million, respectively, associated with the movement, effective on October 1, 2019, of certain products from the Medication Delivery Solutions unit to the Medication Management Solutions unit. | [
{
"currency_/_unit": "USD",
"end_character": 94,
"end_date_for_period": "2019-09-30",
"label": "revenues",
"start_character": 92,
"start_date_for_period": "2018-10-01",
"value": 11000000
},
{
"currency_/_unit": "USD",
"end_character": 110,
"end_date_for_period": "2018-09-30",
"label": "revenues",
"start_character": 108,
"start_date_for_period": "2017-10-01",
"value": 17000000
}
] |
10-K | 0000016099-20-000124 | 20201209161737 | 20200826 | LUBYS INC | We sustained a net loss of $15.2 million and cash flow from operations was a use of cash of $13.1 million for the fiscal year ended August 28, 2019. In the | [
{
"currency_/_unit": "USD",
"end_character": 32,
"end_date_for_period": "2019-08-28",
"label": "earnings",
"start_character": 28,
"start_date_for_period": "2018-08-30",
"value": -15200000
},
{
"currency_/_unit": "USD",
"end_character": 97,
"end_date_for_period": "2019-08-28",
"label": "XBRL-OOS",
"start_character": 93,
"start_date_for_period": "2018-08-30",
"value": -13100000
}
] |
10-K | 0000016099-20-000124 | 20201209161737 | 20200826 | LUBYS INC | (a period prior to the COVID-19 pandemic), we sustained a net loss of $12.1 million and cash flow from operations was a use of cash of $5.9 million. For the full fiscal year ended August 26, 2020 we sustained a net loss of $29.5 million and our cash flow from operations was a use of cash of $21.6 million. | [
{
"currency_/_unit": "USD",
"end_character": 75,
"end_date_for_period": "2020-03-11",
"label": "earnings",
"start_character": 71,
"start_date_for_period": "2019-08-29",
"value": -12100000
},
{
"currency_/_unit": "USD",
"end_character": 139,
"end_date_for_period": "2020-03-11",
"label": "XBRL-OOS",
"start_character": 136,
"start_date_for_period": "2019-08-29",
"value": -5900000
},
{
"currency_/_unit": "USD",
"end_character": 228,
"end_date_for_period": "2020-08-26",
"label": "earnings",
"start_character": 224,
"start_date_for_period": "2019-08-29",
"value": -29500000
},
{
"currency_/_unit": "USD",
"end_character": 297,
"end_date_for_period": "2020-08-26",
"label": "XBRL-OOS",
"start_character": 293,
"start_date_for_period": "2019-08-29",
"value": -21600000
}
] |
10-K | 0000021510-20-000049 | 20201201161017 | 20201003 | COHERENT INC | (2) Includes sales of spare parts, related accessories, and other consumable parts as well as revenues from service agreements, of which $62.4 million for fiscal 2020 was recognized over time. | [
{
"currency_/_unit": "USD",
"end_character": 142,
"end_date_for_period": "2020-10-03",
"label": "revenues",
"start_character": 138,
"start_date_for_period": "2019-09-29",
"value": 62400000
}
] |
10-K | 0000043920-20-000074 | 20201217171652 | 20201031 | GREIF, INC | The non-U.S. income before income tax expense was $160.6 million, $132.1 million and $102.3 million in 2020, 2019, and 2018, respectively. The U.S. income before income tax was $25.5 million, $129.9 million and $197.5 million in 2020, 2019, and 2018, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 56,
"end_date_for_period": "2020-10-31",
"label": "earnings",
"start_character": 51,
"start_date_for_period": "2019-11-01",
"value": 160600000
},
{
"currency_/_unit": "USD",
"end_character": 72,
"end_date_for_period": "2019-10-31",
"label": "earnings",
"start_character": 67,
"start_date_for_period": "2018-11-01",
"value": 132100000
},
{
"currency_/_unit": "USD",
"end_character": 91,
"end_date_for_period": "2018-10-31",
"label": "earnings",
"start_character": 86,
"start_date_for_period": "2017-11-01",
"value": 102300000
},
{
"currency_/_unit": "USD",
"end_character": 182,
"end_date_for_period": "2020-10-31",
"label": "earnings",
"start_character": 178,
"start_date_for_period": "2019-11-01",
"value": 25500000
},
{
"currency_/_unit": "USD",
"end_character": 198,
"end_date_for_period": "2019-10-31",
"label": "earnings",
"start_character": 193,
"start_date_for_period": "2018-11-01",
"value": 129900000
},
{
"currency_/_unit": "USD",
"end_character": 217,
"end_date_for_period": "2018-10-31",
"label": "earnings",
"start_character": 212,
"start_date_for_period": "2017-11-01",
"value": 197500000
}
] |
10-K | 0000794170-20-000066 | 20201222160610 | 20201031 | Toll Brothers, Inc. | In fiscal 2020, 2019 and 2018, purchases from unconsolidated entities principally related to our acquisition of lots from our Land Development Joint Ventures and were $17.6 million, $137.1 million, and $153.2 million, respectively. Our share of income from the lots we acquired was insignificant in each period. Sales to unconsolidated entities principally related to land | [
{
"currency_/_unit": "USD",
"end_character": 172,
"end_date_for_period": "2020-10-31",
"label": "revenues",
"start_character": 168,
"start_date_for_period": "2019-11-01",
"value": 17600000
},
{
"currency_/_unit": "USD",
"end_character": 188,
"end_date_for_period": "2019-10-31",
"label": "revenues",
"start_character": 183,
"start_date_for_period": "2018-11-01",
"value": 137100000
},
{
"currency_/_unit": "USD",
"end_character": 208,
"end_date_for_period": "2018-10-31",
"label": "revenues",
"start_character": 203,
"start_date_for_period": "2017-11-01",
"value": 153200000
}
] |
10-K | 0000812128-20-000017 | 20201217073104 | 20201031 | SANDERSON FARMS INC | Sales of offal are considered by-products; accordingly, these amounts reduce cost of sales and totaled $24.8 million, $31.1 million and $34.4 million in fiscal 2020, 2019 and 2018, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 108,
"end_date_for_period": "2020-10-31",
"label": "revenues",
"start_character": 104,
"start_date_for_period": "2019-11-01",
"value": 24800000
},
{
"currency_/_unit": "USD",
"end_character": 123,
"end_date_for_period": "2019-10-31",
"label": "revenues",
"start_character": 119,
"start_date_for_period": "2018-11-01",
"value": 31100000
},
{
"currency_/_unit": "USD",
"end_character": 141,
"end_date_for_period": "2018-10-31",
"label": "revenues",
"start_character": 137,
"start_date_for_period": "2017-11-01",
"value": 34400000
}
] |
10-K | 0000812128-20-000017 | 20201217073104 | 20201031 | SANDERSON FARMS INC | The Company sells certain of its products either directly to foreign markets or to U.S. based customers who resell the product in foreign markets. These foreign markets for fiscal 2020 were primarily Mexico, China and Cuba, and for fiscal 2019 and 2018 were primarily Mexico, Cuba, Central Asia and the Middle East. These export sales for fiscal years 2020, 2019 and 2018 totaled approximately $308.9 million, $284.5 million and $215.8 million, respectively. The Company does not believe that the amount of sales attributable to any single foreign country is material to its total sales during any of the periods presented. The Company’s export sales are facilitated through independent food brokers located in the United States and the Company’s internal sales staff. | [
{
"currency_/_unit": "USD",
"end_character": 400,
"end_date_for_period": "2020-10-31",
"label": "revenues",
"start_character": 395,
"start_date_for_period": "2019-11-01",
"value": 308900000
},
{
"currency_/_unit": "USD",
"end_character": 416,
"end_date_for_period": "2019-10-31",
"label": "revenues",
"start_character": 411,
"start_date_for_period": "2018-11-01",
"value": 284500000
},
{
"currency_/_unit": "USD",
"end_character": 435,
"end_date_for_period": "2018-10-31",
"label": "revenues",
"start_character": 430,
"start_date_for_period": "2017-11-01",
"value": 215800000
}
] |
10-K | 0000913760-20-000206 | 20201214162208 | 20200930 | StoneX Group Inc. | Gain’s results of operations and cash flows have been included in the Company’s consolidated financial statements for the period subsequent to July 31, 2020. For the year ended September 30, 2020, the Company’s results include total revenues and net income from Gain of $49.0 million and $1.8 million, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 275,
"end_date_for_period": "2020-09-30",
"label": "revenues",
"start_character": 271,
"start_date_for_period": "2019-10-01",
"value": 49000000
},
{
"currency_/_unit": "USD",
"end_character": 292,
"end_date_for_period": "2020-09-30",
"label": "XBRL-OOS",
"start_character": 289,
"start_date_for_period": "2019-10-01",
"value": 1800000
}
] |
10-K | 0000936395-20-000042 | 20201218153247 | 20201031 | CIENA CORP | North America includes $2.25 billion, $2.25 billion and $1.77 billion of United States revenue for fiscal years ended October 31, 2020, November 2, 2019 and November 3, 2018, respectively. No other country accounted for at least 10% of total revenue for the periods presented above. | [
{
"currency_/_unit": "USD",
"end_character": 28,
"end_date_for_period": "2020-10-31",
"label": "revenues",
"start_character": 24,
"start_date_for_period": "2019-11-03",
"value": 2250000000
},
{
"currency_/_unit": "USD",
"end_character": 43,
"end_date_for_period": "2020-10-31",
"label": "revenues",
"start_character": 39,
"start_date_for_period": "2019-11-03",
"value": 2250000000
},
{
"currency_/_unit": "USD",
"end_character": 61,
"end_date_for_period": "2018-11-03",
"label": "revenues",
"start_character": 57,
"start_date_for_period": "2017-11-01",
"value": 1770000000
}
] |
10-K | 0001260221-20-000099 | 20201112135822 | 20200930 | TransDigm Group INC | Sales to foreign customers, primarily in Western Europe, Canada and Asia, were $1,696 million, $1,778 million and $1,355 million during the fiscal years ended 2020, 2019 and 2018. | [
{
"currency_/_unit": "USD",
"end_character": 85,
"end_date_for_period": "2020-09-30",
"label": "revenues",
"start_character": 80,
"start_date_for_period": "2019-10-01",
"value": 1696000000
},
{
"currency_/_unit": "USD",
"end_character": 101,
"end_date_for_period": "2019-09-30",
"label": "revenues",
"start_character": 96,
"start_date_for_period": "2018-10-01",
"value": 1778000000
},
{
"currency_/_unit": "USD",
"end_character": 120,
"end_date_for_period": "2018-09-30",
"label": "revenues",
"start_character": 115,
"start_date_for_period": "2017-10-01",
"value": 1355000000
}
] |
10-K | 0001319161-20-000032 | 20201123074629 | 20200930 | Warner Music Group Corp. | Actual results related to EMP included in the consolidated statement of operations for the fiscal year ended September 30, 2019 relate to the transition period from October 10, 2018 to September 30, 2019 and consist of revenues of $240 million and operating income of $8 million. | [
{
"currency_/_unit": "USD",
"end_character": 235,
"end_date_for_period": "2020-09-30",
"label": "XBRL-OOS",
"start_character": 232,
"start_date_for_period": "2019-10-01",
"value": 240000000
},
{
"currency_/_unit": "USD",
"end_character": 270,
"end_date_for_period": "2020-09-30",
"label": "ebit",
"start_character": 269,
"start_date_for_period": "2019-10-01",
"value": 8000000
}
] |
10-K | 0001350420-20-000010 | 20201223162155 | 20200930 | Lincolnway Energy, LLC | The Company has an agreement with an unrelated entity for marketing, selling and distributing all of the ethanol produced by the Company. Revenues with this customer were approximately $80,097,000, $75,203,000, and $77,736,000 for the years ended September 30, 2020, 2019 and 2018, respectively. Trade accounts receivable of approximately $3,255,000 and $2,447,000 was due from the customer as of September 30, 2020 and 2019, respectively. As of September 30, 2020, the Company has ethanol sales commitments with the unrelated entity of 14.4 million unpriced gallons through December 2021. | [
{
"currency_/_unit": "USD",
"end_character": 197,
"end_date_for_period": "2020-09-30",
"label": "revenues",
"start_character": 187,
"start_date_for_period": "2019-10-01",
"value": 80097000
},
{
"currency_/_unit": "USD",
"end_character": 210,
"end_date_for_period": "2019-09-30",
"label": "revenues",
"start_character": 200,
"start_date_for_period": "2018-10-01",
"value": 75203000
},
{
"currency_/_unit": "USD",
"end_character": 227,
"end_date_for_period": "2018-09-30",
"label": "revenues",
"start_character": 217,
"start_date_for_period": "2017-10-01",
"value": 77736000
},
{
"currency_/_unit": "USD",
"end_character": 351,
"end_date_for_period": "2020-09-30",
"label": "XBRL-OOS",
"start_character": 342,
"start_date_for_period": "2020-09-30",
"value": 3255000
},
{
"currency_/_unit": "USD",
"end_character": 366,
"end_date_for_period": "2019-09-30",
"label": "XBRL-OOS",
"start_character": 357,
"start_date_for_period": "2019-09-30",
"value": 2447000
},
{
"currency_/_unit": "utr:gal",
"end_character": 544,
"end_date_for_period": "2020-09-30",
"label": "XBRL-OOS",
"start_character": 540,
"start_date_for_period": "2020-09-30",
"value": 14400000
}
] |
10-K | 0001350420-20-000010 | 20201223162155 | 20200930 | Lincolnway Energy, LLC | The Company also has an agreement with an unrelated entity for marketing, selling and distributing the distillers grains. Revenues with this customer, including both distillers grains and corn oil, were $19,196,000, $15,329,000 and $16,933,000 for the years ended September 30, 2020, 2019 and 2018 , respectively. Trade accounts receivable of $685,000 and $541,000 was due from the customer as of September 30, 2020 and 2019, respectively. The Company has distillers grain sales commitments with the unrelated entity of approximately 16,000 | [
{
"currency_/_unit": "USD",
"end_character": 215,
"end_date_for_period": "2020-09-30",
"label": "revenues",
"start_character": 205,
"start_date_for_period": "2019-10-01",
"value": 19196000
},
{
"currency_/_unit": "USD",
"end_character": 228,
"end_date_for_period": "2019-09-30",
"label": "revenues",
"start_character": 218,
"start_date_for_period": "2018-10-01",
"value": 15329000
},
{
"currency_/_unit": "USD",
"end_character": 244,
"end_date_for_period": "2018-09-30",
"label": "revenues",
"start_character": 234,
"start_date_for_period": "2017-10-01",
"value": 16933000
},
{
"currency_/_unit": "USD",
"end_character": 352,
"end_date_for_period": "2020-09-30",
"label": "XBRL-OOS",
"start_character": 345,
"start_date_for_period": "2020-09-30",
"value": 685000
},
{
"currency_/_unit": "USD",
"end_character": 365,
"end_date_for_period": "2019-09-30",
"label": "XBRL-OOS",
"start_character": 358,
"start_date_for_period": "2019-09-30",
"value": 541000
},
{
"currency_/_unit": "utr:T",
"end_character": 543,
"end_date_for_period": "2020-09-30",
"label": "XBRL-OOS",
"start_character": 537,
"start_date_for_period": "2019-10-01",
"value": 16000
}
] |
10-K | 0001403161-20-000070 | 20201119160334 | 20200930 | VISA INC. | Weighted-average diluted shares outstanding are calculated on an as-converted basis, and include incremental common stock equivalents, as calculated under the treasury stock method. The computation includes 3 million common stock equivalents for each of fiscal 2020, 2019 and 2018 because their effect would have been dilutive. The computation excludes 1 million of common stock equivalents for each of fiscal 2020, 2019 and 2018, because their effect would have been anti-dilutive. | [
{
"currency_/_unit": "shares",
"end_character": 208,
"end_date_for_period": "2020-09-30",
"label": "eps",
"start_character": 207,
"start_date_for_period": "2019-10-01",
"value": 3000000
},
{
"currency_/_unit": "shares",
"end_character": 270,
"end_date_for_period": "2020-09-30",
"label": "XBRL-OOS",
"start_character": 269,
"start_date_for_period": "2019-10-01",
"value": 1000000
}
] |
10-K | 0001406587-20-000087 | 20201119143838 | 20200930 | Forestar Group Inc. | Land and lot sales to D.R. Horton were $887.6 million, $326.6 million and $39.1 million in fiscal 2020, 2019 and the nine months ended September 30, 2018, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 45,
"end_date_for_period": "2020-09-30",
"label": "revenues",
"start_character": 40,
"start_date_for_period": "2019-10-01",
"value": 887600000
},
{
"currency_/_unit": "USD",
"end_character": 61,
"end_date_for_period": "2019-09-30",
"label": "revenues",
"start_character": 56,
"start_date_for_period": "2018-10-01",
"value": 326600000
},
{
"currency_/_unit": "USD",
"end_character": 79,
"end_date_for_period": "2018-09-30",
"label": "revenues",
"start_character": 75,
"start_date_for_period": "2018-01-01",
"value": 39100000
}
] |
10-K | 0001417398-20-000042 | 20201112062440 | 20200930 | Hillenbrand, Inc. | On November 21, 2019, we completed the acquisition of Milacron, which includes its existing information systems and internal controls over financial reporting. In conducting our evaluation of the effectiveness of our internal control over financial reporting for our fiscal year ended September 30, 2020, we have excluded Milacron from our evaluation as permitted under existing SEC Staff interpretive guidance for newly acquired businesses. We are currently in the process of evaluating and integrating Milacron’s historical internal control over financial reporting with ours. The integration may lead to changes in future fiscal periods, but we do not expect these changes to materially affect our internal control over financial reporting. We expect to complete this integration in fiscal 2021. For the year ended September 30, 2020, Milacron accounted for $735.8 of our total net revenue, and as of September 30, 2020, had total assets of $2,032.4 (inclusive of acquired goodwill and identifiable intangible assets of $1,297.5). | [
{
"currency_/_unit": "USD",
"end_character": 871,
"end_date_for_period": "2020-09-30",
"label": "revenues",
"start_character": 866,
"start_date_for_period": "2019-10-01",
"value": 735800000
},
{
"currency_/_unit": "USD",
"end_character": 956,
"end_date_for_period": "2020-09-30",
"label": "XBRL-OOS",
"start_character": 949,
"start_date_for_period": "2020-09-30",
"value": 2032400000
}
] |
10-K | 0001423221-20-000021 | 20201211160330 | 20201031 | Quanex Building Products CORP | We record the estimated future tax effects of temporary differences between the tax basis of assets and liabilities and the amounts reported in our consolidated balance sheets, as well as net operating losses and tax credit carry forwards. We evaluate the carrying value of the net deferred tax assets and determine whether we will be able to generate sufficient future taxable income to realize our deferred tax assets. We perform this review for recoverability on a jurisdictional basis, whereby we consider both positive and negative evidence related to the likelihood of realization of the deferred tax assets. The weight given to the positive and negative evidence is commensurate with the extent to which the evidence can be objectively verified. Cumulative losses in recent years is a significant piece of negative evidence that is difficult to overcome in determining that a valuation allowance is not needed against deferred tax assets. Thus, it is generally difficult for positive evidence regarding projected future taxable income exclusive of reversing taxable temporary differences to outweigh objective negative evidence of recent financial reporting losses. We recorded net income for the years ended October 31, 2020 and October 31, 2018 and net loss for the year ended October 31, 2019. We have recorded pre-tax cumulative income from operations of $40.1 million for the three-year period ended October 31, 2020. We believe we will fully realize our deferred tax assets, net of a recorded valuation allowance. We project future taxable income using the same forecasts used to test long-lived assets and intangibles for impairment, scheduling out the future reversal of existing taxable temporary differences and reviewing our most recent financial operations. In the event the estimates and assumptions indicate we will not generate sufficient future taxable income to realize our deferred tax assets, we record a valuation allowance against a portion of our deferred tax assets. | [
{
"currency_/_unit": "USD",
"end_character": 1374,
"end_date_for_period": "2020-10-31",
"label": "earnings",
"start_character": 1370,
"start_date_for_period": "2017-11-01",
"value": 40100000
}
] |
10-K | 0001493594-20-000063 | 20201118160839 | 20201002 | MACOM Technology Solutions Holdings, Inc. | For fiscal years 2020, 2019 and 2018, the effective tax rates on $41.6 million, $423.2 million and $155.2 million, respectively, of pre-tax loss from continuing operations were (10.9)%, 9.3% and 13.8%, respectively. The effective income tax rates for fiscal years 2020, 2019 and 2018 were impacted by a lower income tax rate in many foreign jurisdictions in which our foreign subsidiaries operate, changes in valuation allowance, research and development tax credits, and a fair market value adjustment of warrant liability. For fiscal year 2020, the effective tax rate was also impacted by an adjustment in our Section 382 limitation which increased our | [
{
"currency_/_unit": "USD",
"end_character": 70,
"end_date_for_period": "2020-10-02",
"label": "earnings",
"start_character": 66,
"start_date_for_period": "2019-09-28",
"value": -41600000
},
{
"currency_/_unit": "USD",
"end_character": 86,
"end_date_for_period": "2019-09-27",
"label": "earnings",
"start_character": 81,
"start_date_for_period": "2018-09-29",
"value": -423200000
},
{
"currency_/_unit": "USD",
"end_character": 105,
"end_date_for_period": "2018-09-28",
"label": "earnings",
"start_character": 100,
"start_date_for_period": "2017-09-30",
"value": -155200000
},
{
"currency_/_unit": "pure",
"end_character": 182,
"end_date_for_period": "2020-10-02",
"label": "XBRL-OOS",
"start_character": 178,
"start_date_for_period": "2019-09-28",
"value": -0.109
},
{
"currency_/_unit": "pure",
"end_character": 189,
"end_date_for_period": "2019-09-27",
"label": "XBRL-OOS",
"start_character": 186,
"start_date_for_period": "2018-09-29",
"value": 0.093
},
{
"currency_/_unit": "pure",
"end_character": 199,
"end_date_for_period": "2018-09-28",
"label": "XBRL-OOS",
"start_character": 195,
"start_date_for_period": "2017-09-30",
"value": 0.138
}
] |
10-K | 0001498301-20-000105 | 20201211061318 | 20200801 | Ascena Retail Group, Inc. | Ascena Retail Group, Inc., a Delaware corporation, is a national specialty retailer of apparel for women and tween girls. The Company's continuing operations consist of its direct channel operations and approximately 2,500 stores throughout the United States, Canada and Puerto Rico. The Company had annual revenues for the fiscal year ended August 1, 2020 of approximately $3.7 billion. The Company and its subsidiaries are collectively referred to herein as the “Company,” “ascena,” “we,” “us,” “our” and “ourselves,” unless the context indicates otherwise. | [
{
"currency_/_unit": "asna:Store",
"end_character": 222,
"end_date_for_period": "2020-08-01",
"label": "XBRL-OOS",
"start_character": 217,
"start_date_for_period": "2020-08-01",
"value": 2500
},
{
"currency_/_unit": "USD",
"end_character": 379,
"end_date_for_period": "2020-08-01",
"label": "revenues",
"start_character": 376,
"start_date_for_period": "2019-08-04",
"value": 3700000000
}
] |
10-K | 0001632790-20-000094 | 20201117152113 | 20200930 | ENERGIZER HOLDINGS, INC. | For the twelve months ended September 30, 2020 the Company has recorded a pre-tax loss of $141.6 for the divestment, which includes contractual adjustments and recognition of tax and other indemnifications under the definitive purchase agreement. Under the definitive purchase agreement, the Company indemnified VARTA AG for certain tax liabilities that existed as of the divestment date. As previously disclosed, Spectrum has further indemnified the Company for those liabilities that arose from the tax years prior to the Company's acquisition of the Divestment Business. An indemnification asset and liability, where necessary, has been recorded to reflect these arrangements. | [
{
"currency_/_unit": "USD",
"end_character": 96,
"end_date_for_period": "2020-09-30",
"label": "earnings",
"start_character": 91,
"start_date_for_period": "2019-10-01",
"value": -141600000
}
] |
10-K | 0001663577-20-000499 | 20201217172247 | 20200930 | CLEANSPARK, INC. | As shown in the accompanying consolidated financial
statements, the Company incurred net losses of $23,346,143
| [
{
"currency_/_unit": "USD",
"end_character": 110,
"end_date_for_period": "2020-09-30",
"label": "earnings",
"start_character": 100,
"start_date_for_period": "2019-10-01",
"value": -23346143
}
] |
10-K | 0001670541-20-000080 | 20201130071125 | 20200930 | Adient plc | On December 31, 2019, Adient sold the RECARO automotive high performance seating systems business to a group of investors for de minimis proceeds. As a result of the sale, Adient recorded a loss of $21 million during the quarter ending December 31, 2019. For fiscal 2019, the RECARO business recorded $148 million of net sales and insignificant pre-tax income. | [
{
"currency_/_unit": "USD",
"end_character": 201,
"end_date_for_period": "2019-12-31",
"label": "XBRL-OOS",
"start_character": 199,
"start_date_for_period": "2019-10-01",
"value": -21000000
},
{
"currency_/_unit": "USD",
"end_character": 305,
"end_date_for_period": "2019-09-30",
"label": "revenues",
"start_character": 302,
"start_date_for_period": "2018-10-01",
"value": 148000000
}
] |
10-K | 0001674910-20-000221 | 20201124170123 | 20200930 | VALVOLINE INC | Operating and pre-tax income include the matters noted in (a), as well as adjustments associated with legacy and separation-related matters, restructuring activities, acquisition and divestiture-related activity, and business interruption recoveries. Restructuring expense of $1 million and $1 million of legacy and separation-related income were recognized in the first fiscal quarter of 2020, combining for no net impact on operating and pre-tax income. In the second fiscal quarter of 2020, $2 million of acquisition and divestiture-related expenses were incurred, and in the prior year period, legacy and separation-related and restructuring and related expenses were recognized of $3 million and $8 million, respectively. Expenses associated with legacy and separation-related matters and restructuring of $1 million and $4 million were recognized in the third fiscal quarters of 2020 and 2019, respectively. In the fourth fiscal quarter of 2020, income associated with legacy and separation-related adjustments, the compensated absences benefits change, business interruption recoveries, and restructuring were recognized of $30 million, $6 million (in addition to the benefit noted in (a) above), $2 million, and $1 million, respectively. In the fourth quarter of fiscal 2019, income associated with an acquisition-related bargain purchase gain of $4 million was partially offset by $2 million of restructuring and related expenses. | [
{
"currency_/_unit": "USD",
"end_character": 278,
"end_date_for_period": "2019-12-31",
"label": "ebit",
"start_character": 277,
"start_date_for_period": "2019-10-01",
"value": 1000000
},
{
"currency_/_unit": "USD",
"end_character": 293,
"end_date_for_period": "2019-12-31",
"label": "ebit",
"start_character": 292,
"start_date_for_period": "2019-10-01",
"value": 1000000
},
{
"currency_/_unit": "USD",
"end_character": 390,
"end_date_for_period": "2020-03-31",
"label": "ebit",
"start_character": 389,
"start_date_for_period": "2020-01-01",
"value": -2000000
},
{
"currency_/_unit": "USD",
"end_character": 688,
"end_date_for_period": "2019-03-31",
"label": "ebit",
"start_character": 687,
"start_date_for_period": "2019-01-01",
"value": -3000000
},
{
"currency_/_unit": "USD",
"end_character": 703,
"end_date_for_period": "2019-03-31",
"label": "ebit",
"start_character": 702,
"start_date_for_period": "2019-01-01",
"value": -8000000
},
{
"currency_/_unit": "USD",
"end_character": 813,
"end_date_for_period": "2019-12-31",
"label": "ebit",
"start_character": 812,
"start_date_for_period": "2019-10-01",
"value": 1000000
},
{
"currency_/_unit": "USD",
"end_character": 828,
"end_date_for_period": "2019-06-30",
"label": "ebit",
"start_character": 827,
"start_date_for_period": "2019-04-01",
"value": -4000000
},
{
"currency_/_unit": "USD",
"end_character": 1134,
"end_date_for_period": "2020-09-30",
"label": "ebit",
"start_character": 1132,
"start_date_for_period": "2020-07-01",
"value": -30000000
},
{
"currency_/_unit": "USD",
"end_character": 1146,
"end_date_for_period": "2020-09-30",
"label": "ebit",
"start_character": 1145,
"start_date_for_period": "2020-07-01",
"value": -6000000
},
{
"currency_/_unit": "USD",
"end_character": 1206,
"end_date_for_period": "2020-03-31",
"label": "ebit",
"start_character": 1205,
"start_date_for_period": "2020-01-01",
"value": -2000000
},
{
"currency_/_unit": "USD",
"end_character": 1222,
"end_date_for_period": "2019-12-31",
"label": "ebit",
"start_character": 1221,
"start_date_for_period": "2019-10-01",
"value": 1000000
},
{
"currency_/_unit": "USD",
"end_character": 1357,
"end_date_for_period": "2019-06-30",
"label": "ebit",
"start_character": 1356,
"start_date_for_period": "2019-04-01",
"value": -4000000
},
{
"currency_/_unit": "USD",
"end_character": 1392,
"end_date_for_period": "2020-03-31",
"label": "ebit",
"start_character": 1391,
"start_date_for_period": "2020-01-01",
"value": -2000000
}
] |
10-K | 0001728949-20-000067 | 20201104171944 | 20200927 | QUALCOMM INC/DE | Based on this evaluation, we concluded that the revenue recognition criteria were met, and we recorded revenues of $1.8 billion in the fourth quarter of fiscal 2020 related to the full amount due from Huawei under the settlement agreement and amounts paid for the March 2020 and June 2020 quarters under the new global patent license agreement. In addition, QTL results for the fourth quarter of fiscal 2020 included estimated royalties due from Huawei for sales made in the September 2020 quarter under the new global patent license agreement. | [
{
"currency_/_unit": "USD",
"end_character": 119,
"end_date_for_period": "2020-09-27",
"label": "revenues",
"start_character": 116,
"start_date_for_period": "2020-06-29",
"value": 1800000000
}
] |
10-K | 0001728949-20-000067 | 20201104171944 | 20200927 | QUALCOMM INC/DE | In fiscal 2018, all of the costs ($474 million) related to pre-commercial research and development of 5G technologies were included in unallocated corporate research and development expenses, whereas similar costs related to the research and development of other technologies, including 3G and 4G technologies, were recorded in the QCT and QTL segments. Beginning in fiscal 2019, all research and development costs associated with 5G technologies were included in segment results. Additionally, beginning in fiscal 2019, certain research and development costs associated with early research and development that were historically included in our QCT segment were allocated to our QTL segment. The net effect of these changes negatively impacted QTL’s EBT by $489 million in fiscal 2019 and positively impacted QCT’s EBT by $160 million in fiscal 2019. | [
{
"currency_/_unit": "USD",
"end_character": 38,
"end_date_for_period": "2018-09-30",
"label": "XBRL-OOS",
"start_character": 35,
"start_date_for_period": "2017-09-25",
"value": 474000000
},
{
"currency_/_unit": "USD",
"end_character": 762,
"end_date_for_period": "2019-09-29",
"label": "earnings",
"start_character": 759,
"start_date_for_period": "2018-10-01",
"value": 489000000
},
{
"currency_/_unit": "USD",
"end_character": 827,
"end_date_for_period": "2019-09-29",
"label": "earnings",
"start_character": 824,
"start_date_for_period": "2018-10-01",
"value": 160000000
}
] |
10-K | 0001730168-20-000226 | 20201218170710 | 20201101 | Broadcom Inc. | Our results of continuing operations for fiscal year 2020 included $1,610 million of net revenue attributable to the Symantec Business. It was impracticable to determine the effect on net income attributable to the Symantec Business as we had integrated the Symantec Business into our ongoing operations during the year. The results of operations of the Symantec Business were included in our infrastructure software segment. Transaction costs related to the Symantec Asset Purchase of $110 million were included in selling, general and administrative expense for fiscal year 2020. | [
{
"currency_/_unit": "USD",
"end_character": 73,
"end_date_for_period": "2020-11-01",
"label": "revenues",
"start_character": 68,
"start_date_for_period": "2019-11-04",
"value": 1610000000
},
{
"currency_/_unit": "USD",
"end_character": 490,
"end_date_for_period": "2020-11-01",
"label": "XBRL-OOS",
"start_character": 487,
"start_date_for_period": "2019-11-04",
"value": 110000000
}
] |
10-K | 0001730168-20-000226 | 20201218170710 | 20201101 | Broadcom Inc. | Our results of continuing operations for fiscal year 2019 included $3,377 million of net revenue attributable to CA. It was impracticable to determine the effect on net income attributable to CA as we had integrated a substantial portion of CA into our ongoing operations during the year. The results of operations of CA were included in our infrastructure software segment. Transaction costs related to the CA Merger of $73 million were included in selling, general and administrative expense for fiscal year 2019. | [
{
"currency_/_unit": "USD",
"end_character": 73,
"end_date_for_period": "2019-11-03",
"label": "revenues",
"start_character": 68,
"start_date_for_period": "2018-11-05",
"value": 3377000000
},
{
"currency_/_unit": "USD",
"end_character": 424,
"end_date_for_period": "2019-11-03",
"label": "XBRL-OOS",
"start_character": 422,
"start_date_for_period": "2018-11-05",
"value": 73000000
}
] |
10-K | 0001730168-20-000226 | 20201218170710 | 20201101 | Broadcom Inc. | Our results of continuing operations for fiscal year 2018 included $1,780 million of net revenue attributable to Brocade. It was impracticable to determine the effect on net income attributable to Brocade as we had integrated a substantial portion of Brocade into our ongoing operations. The results of operations of Brocade were primarily included in our infrastructure software segment. Transaction costs of $29 million related to the Brocade Merger were included in selling, general and administrative expense for fiscal year 2018. | [
{
"currency_/_unit": "USD",
"end_character": 73,
"end_date_for_period": "2018-11-04",
"label": "revenues",
"start_character": 68,
"start_date_for_period": "2017-10-30",
"value": 1780000000
},
{
"currency_/_unit": "USD",
"end_character": 413,
"end_date_for_period": "2018-11-04",
"label": "XBRL-OOS",
"start_character": 411,
"start_date_for_period": "2017-10-30",
"value": 29000000
}
] |
10-K | 0001772016-20-000070 | 20201120134629 | 20200930 | BELLRING BRANDS, INC. | The following table summarizes the impact of the Company’s adoption of Accounting Standards Codification (“ASC”) Topic 606 on a modified retrospective basis in the Company’s Consolidated Statement of Operations for the year ended September 30, 2019. As a result of the adoption, certain payments to customers totaling $8.8 in the year ended September 30, 2019 previously classified in “Selling, general and administrative expenses” were classified as “Net Sales” in the Consolidated Statement of Operations. These payments to customers related to trade advertisements that supported the Company’s sales to customers. In accordance with ASC Topic 606, these payments were determined not to be distinct within the customer contracts and, as such, required classification within net sales. No changes to the balance sheet were required by the adoption of ASC Topic 606. | [
{
"currency_/_unit": "USD",
"end_character": 322,
"end_date_for_period": "2019-09-30",
"label": "revenues",
"start_character": 319,
"start_date_for_period": "2018-10-01",
"value": -8800000
}
] |
10-Q | 0001596783-20-000017 | 20200203083304 | 20191231 | Catalent, Inc. | The Company recorded a provision for income taxes for the three months ended December 31, 2019 of $13.0 million relative to earnings from operations before income taxes of $58.5 million. The Company recorded a provision for income taxes for the three months ended December 31, 2018 of $2.3 million relative to earnings from operations before income taxes of $51.3 million. | [
{
"currency_/_unit": "USD",
"end_character": 104,
"end_date_for_period": "2019-12-31",
"label": "XBRL-OOS",
"start_character": 100,
"start_date_for_period": "2019-10-01",
"value": 13000000
},
{
"currency_/_unit": "USD",
"end_character": 178,
"end_date_for_period": "2019-12-31",
"label": "earnings",
"start_character": 174,
"start_date_for_period": "2019-10-01",
"value": 58500000
},
{
"currency_/_unit": "USD",
"end_character": 290,
"end_date_for_period": "2018-12-31",
"label": "XBRL-OOS",
"start_character": 287,
"start_date_for_period": "2018-10-01",
"value": 2300000
},
{
"currency_/_unit": "USD",
"end_character": 364,
"end_date_for_period": "2018-12-31",
"label": "earnings",
"start_character": 360,
"start_date_for_period": "2018-10-01",
"value": 51300000
}
] |
10-Q | 0001530721-20-000008 | 20200205160734 | 20191228 | Capri Holdings Ltd | Versace’s results of operations have been included in our consolidated financial statements beginning on December 31, 2018. Versace contributed total revenue of $195 million and $630 million, respectively, for the three and nine months ended November 30, 2019 and net loss from operations of $12 million and $6 million, respectively, after amortization of non-cash purchase accounting adjustments, for the three and nine months ended November 30, 2019 (reflecting a one-month reporting lag). | [
{
"currency_/_unit": "USD",
"end_character": 165,
"end_date_for_period": "2019-11-30",
"label": "XBRL-OOS",
"start_character": 162,
"start_date_for_period": "2019-09-01",
"value": 195000000
},
{
"currency_/_unit": "USD",
"end_character": 182,
"end_date_for_period": "2019-11-30",
"label": "XBRL-OOS",
"start_character": 179,
"start_date_for_period": "2019-03-01",
"value": 630000000
},
{
"currency_/_unit": "USD",
"end_character": 295,
"end_date_for_period": "2019-11-30",
"label": "earnings",
"start_character": 293,
"start_date_for_period": "2019-09-01",
"value": -12000000
},
{
"currency_/_unit": "USD",
"end_character": 310,
"end_date_for_period": "2019-11-30",
"label": "earnings",
"start_character": 309,
"start_date_for_period": "2019-03-01",
"value": -6000000
}
] |
10-Q | 0001670541-20-000004 | 20200207161338 | 20191231 | Adient plc | On December 31, 2019, Adient sold the RECARO automotive high performance seating systems business to a group of investors for de minimis proceeds. As a result of the sale, Adient recorded a loss of $21 million during the quarter ending December 31, 2019. For the three months ended December 31, 2019 and 2018, the RECARO business recorded $34 million (Americas: $10 million, EMEA: $11 million, Asia: $13 million) and $32 million (Americas: $11 million, EMEA: $10 million, Asia: $11 million) of net sales and immaterial amounts of net income, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 201,
"end_date_for_period": "2019-12-31",
"label": "XBRL-OOS",
"start_character": 199,
"start_date_for_period": "2019-10-01",
"value": -21000000
},
{
"currency_/_unit": "USD",
"end_character": 342,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 340,
"start_date_for_period": "2019-10-01",
"value": 34000000
},
{
"currency_/_unit": "USD",
"end_character": 365,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 363,
"start_date_for_period": "2019-10-01",
"value": 10000000
},
{
"currency_/_unit": "USD",
"end_character": 384,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 382,
"start_date_for_period": "2019-10-01",
"value": 11000000
},
{
"currency_/_unit": "USD",
"end_character": 403,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 401,
"start_date_for_period": "2019-10-01",
"value": 13000000
},
{
"currency_/_unit": "USD",
"end_character": 420,
"end_date_for_period": "2018-12-31",
"label": "revenues",
"start_character": 418,
"start_date_for_period": "2018-10-01",
"value": 32000000
},
{
"currency_/_unit": "USD",
"end_character": 443,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 441,
"start_date_for_period": "2019-10-01",
"value": 11000000
},
{
"currency_/_unit": "USD",
"end_character": 462,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 460,
"start_date_for_period": "2019-10-01",
"value": 10000000
},
{
"currency_/_unit": "USD",
"end_character": 481,
"end_date_for_period": "2019-12-31",
"label": "revenues",
"start_character": 479,
"start_date_for_period": "2019-10-01",
"value": 11000000
}
] |
10-Q | 0001628280-20-003692 | 20200317070309 | 20190930 | BAXTER INTERNATIONAL INC | The $26 million decrease to net income was driven by the items described above in the condensed consolidated statement of income for the three months ended September 30, 2018 section. | [
{
"currency_/_unit": "USD",
"end_character": 7,
"end_date_for_period": "2018-09-30",
"label": "earnings",
"start_character": 5,
"start_date_for_period": "2018-07-01",
"value": -26000000
}
] |
10-Q | 0001628280-20-003692 | 20200317070309 | 20190930 | BAXTER INTERNATIONAL INC | The $35 million decrease to net income was driven by the items described above in the condensed consolidated statement of income for the nine months ended September 30, 2018 section. | [
{
"currency_/_unit": "USD",
"end_character": 7,
"end_date_for_period": "2018-09-30",
"label": "earnings",
"start_character": 5,
"start_date_for_period": "2018-01-01",
"value": -35000000
}
] |
10-Q | 0001628280-20-003692 | 20200317070309 | 20190930 | BAXTER INTERNATIONAL INC | The $35 million decrease to net income was driven by the items described above in the condensed consolidated statement of income for the nine months ended September 30, 2018 section. | [
{
"currency_/_unit": "USD",
"end_character": 7,
"end_date_for_period": "2018-09-30",
"label": "earnings",
"start_character": 5,
"start_date_for_period": "2018-01-01",
"value": -35000000
}
] |
10-Q | 0001049521-20-000009 | 20200204163726 | 20191227 | MERCURY SYSTEMS INC | The revenues and income before income taxes from APC included in the Company's consolidated results for the second quarter ended December 27, 2019 were $9,653 and $1,495, respectively. The revenues and income before income taxes from APC included in the Company's consolidated results for the six months ended December 27, 2019 were $10,596 and $1,802, respectively. The APC results include expenses resulting from purchase accounting which include amortization of intangible assets and inventory step-up. | [
{
"currency_/_unit": "USD",
"end_character": 158,
"end_date_for_period": "2019-12-27",
"label": "revenues",
"start_character": 153,
"start_date_for_period": "2019-09-28",
"value": 9653
},
{
"currency_/_unit": "USD",
"end_character": 169,
"end_date_for_period": "2019-12-27",
"label": "earnings",
"start_character": 164,
"start_date_for_period": "2019-09-28",
"value": 1495
},
{
"currency_/_unit": "USD",
"end_character": 340,
"end_date_for_period": "2019-12-27",
"label": "revenues",
"start_character": 334,
"start_date_for_period": "2019-07-01",
"value": 10596
},
{
"currency_/_unit": "USD",
"end_character": 351,
"end_date_for_period": "2019-12-27",
"label": "earnings",
"start_character": 346,
"start_date_for_period": "2019-07-01",
"value": 1802
}
] |
10-Q | 0001049521-20-000009 | 20200204163726 | 20191227 | MERCURY SYSTEMS INC | The Company recorded an income tax provision of $5,110 and $4,483 on income from operations before income taxes of $20,786 and $16,866 for the second quarters ended December 27, 2019 and December 31, 2018, respectively. The Company recorded an income tax provision of $3,092 and $7,612 on income from operations before income taxes of $38,015 and $27,474 for the six months ended December 27, 2019 and December 31, 2018, respectively. | [
{
"currency_/_unit": "USD",
"end_character": 54,
"end_date_for_period": "2019-12-27",
"label": "XBRL-OOS",
"start_character": 49,
"start_date_for_period": "2019-09-28",
"value": 5110000
},
{
"currency_/_unit": "USD",
"end_character": 65,
"end_date_for_period": "2018-12-31",
"label": "XBRL-OOS",
"start_character": 60,
"start_date_for_period": "2018-10-01",
"value": 4483000
},
{
"currency_/_unit": "USD",
"end_character": 122,
"end_date_for_period": "2019-12-27",
"label": "earnings",
"start_character": 116,
"start_date_for_period": "2019-09-28",
"value": 20786000
},
{
"currency_/_unit": "USD",
"end_character": 134,
"end_date_for_period": "2018-12-31",
"label": "earnings",
"start_character": 128,
"start_date_for_period": "2018-10-01",
"value": 16866000
},
{
"currency_/_unit": "USD",
"end_character": 274,
"end_date_for_period": "2019-12-27",
"label": "XBRL-OOS",
"start_character": 269,
"start_date_for_period": "2019-07-01",
"value": 3092000
},
{
"currency_/_unit": "USD",
"end_character": 285,
"end_date_for_period": "2018-12-31",
"label": "XBRL-OOS",
"start_character": 280,
"start_date_for_period": "2018-07-01",
"value": 7612000
},
{
"currency_/_unit": "USD",
"end_character": 342,
"end_date_for_period": "2019-12-27",
"label": "earnings",
"start_character": 336,
"start_date_for_period": "2019-07-01",
"value": 38015000
},
{
"currency_/_unit": "USD",
"end_character": 354,
"end_date_for_period": "2018-12-31",
"label": "earnings",
"start_character": 348,
"start_date_for_period": "2018-07-01",
"value": 27474000
}
] |
10-Q | 0000016732-20-000018 | 20200304075138 | 20200126 | CAMPBELL SOUP CO | On October 11, 2019, we completed the sale of our European chips business for £63, or $77. The European chips business had net sales of $25 for the six-month period ended January 26, 2020. The European chips business had net sales of $32 for the three-month period and $60 for the six-month period ended January 27, 2019. Earnings were not material in either period. The results of the European chips business through the date of sale were reflected in continuing operations within the Snacks reportable segment. The pre-tax loss recognized in the first quarter on the sale was $64, which included the impact of allocated goodwill and foreign currency translation adjustments. For tax purposes, the capital loss on the sale was offset by a valuation allowance. | [
{
"currency_/_unit": "GBP",
"end_character": 81,
"end_date_for_period": "2020-01-26",
"label": "XBRL-OOS",
"start_character": 79,
"start_date_for_period": "2019-07-29",
"value": 63000000
},
{
"currency_/_unit": "USD",
"end_character": 89,
"end_date_for_period": "2020-01-26",
"label": "XBRL-OOS",
"start_character": 87,
"start_date_for_period": "2019-07-29",
"value": 77000000
},
{
"currency_/_unit": "USD",
"end_character": 139,
"end_date_for_period": "2020-01-26",
"label": "revenues",
"start_character": 137,
"start_date_for_period": "2019-07-29",
"value": 25000000
},
{
"currency_/_unit": "USD",
"end_character": 237,
"end_date_for_period": "2019-01-27",
"label": "revenues",
"start_character": 235,
"start_date_for_period": "2018-10-29",
"value": 32000000
},
{
"currency_/_unit": "USD",
"end_character": 272,
"end_date_for_period": "2019-01-27",
"label": "revenues",
"start_character": 270,
"start_date_for_period": "2018-07-30",
"value": 60000000
},
{
"currency_/_unit": "USD",
"end_character": 581,
"end_date_for_period": "2020-01-26",
"label": "XBRL-OOS",
"start_character": 579,
"start_date_for_period": "2019-07-29",
"value": -64000000
}
] |
10-Q | 0001412408-20-000028 | 20200609161019 | 20200430 | Phreesia, Inc. | During the three months ended April 30, 2020, the Company recognized $1,554 in subscription and related services revenue related to the leasing of PhreesiaPads and Arrival Stations. | [
{
"currency_/_unit": "USD",
"end_character": 75,
"end_date_for_period": "2020-04-30",
"label": "revenues",
"start_character": 70,
"start_date_for_period": "2020-02-01",
"value": 1554000
}
] |
10-Q | 0001353283-20-000024 | 20200601160200 | 20200430 | SPLUNK INC | As we expect to settle the principal amount of our convertible senior notes in cash, we use the treasury stock method for calculating any potential dilutive effect on diluted net income per share, if applicable. The conversion spread of 14.3 million shares will have a dilutive impact on diluted net income per share of common stock when the average market price of our common stock for a given period exceeds the conversion price of $148.30 per share. | [
{
"currency_/_unit": "shares",
"end_character": 241,
"end_date_for_period": "2020-04-30",
"label": "eps",
"start_character": 237,
"start_date_for_period": "2020-02-01",
"value": 14300000
},
{
"currency_/_unit": null,
"end_character": 441,
"end_date_for_period": "2018-09-21",
"label": "XBRL-OOS",
"start_character": 435,
"start_date_for_period": "2018-09-21",
"value": 148.3
}
] |
10-Q | 0001628280-20-004602 | 20200403165641 | 20200223 | LANDEC CORP \CA\ | In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes (“ASU 2019-12”). ASU 2019-12 eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. It also clarifies and simplifies other aspects of the accounting for income taxes. ASU 2019-12 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 20, 2020. The Company early adopted this guidance in the third quarter of fiscal year 2020, which had a favorable impact of $0.4 million for the three months then ended. This early adoption had no impact to the Company’s prior financial statements, nor will it have any impact to its full year fiscal 2020 financial statements. | [
{
"currency_/_unit": "USD",
"end_character": 677,
"end_date_for_period": "2020-02-23",
"label": "earnings",
"start_character": 674,
"start_date_for_period": "2019-11-25",
"value": 400000
}
] |
10-Q | 0001305323-20-000036 | 20200429161935 | 20200331 | Zovio Inc | The assets and liabilities of Fullstack were recorded on the Company’s condensed consolidated balance sheets at their preliminary estimated fair values as of April 1, 2019, the acquisition date. Fullstack’s results of operations are included in the Company’s condensed consolidated statements of income (loss) from that date. Fullstack recognized revenue of $3.5 million, had an operating loss of $3.1 million, and net loss of $3.1 million for the three months ended March 31, 2020. The Company accounts for business combinations using the acquisition method of accounting. | [
{
"currency_/_unit": "USD",
"end_character": 362,
"end_date_for_period": "2020-03-31",
"label": "revenues",
"start_character": 359,
"start_date_for_period": "2020-01-01",
"value": 3500000
},
{
"currency_/_unit": "USD",
"end_character": 401,
"end_date_for_period": "2020-03-31",
"label": "ebit",
"start_character": 398,
"start_date_for_period": "2020-01-01",
"value": 3100000
},
{
"currency_/_unit": "USD",
"end_character": 431,
"end_date_for_period": "2020-03-31",
"label": "ebit",
"start_character": 428,
"start_date_for_period": "2020-01-01",
"value": 3100000
}
] |
10-Q | 0001305323-20-000036 | 20200429161935 | 20200331 | Zovio Inc | The Fullstack Contingent Consideration will become issuable, subject to the terms and conditions of the Fullstack Merger Agreement. Of the total contingent 2,250,000 shares, (i) 1,250,000 are based upon final determination of the achievement of certain employee retention requirements and is being expensed over the retention period, (ii) 500,000 shares are based upon revenue performance in 2019 and 2020, earned on a sliding scale, in the event that the revenues for Fullstack are between $25.0 million and $35.0 million, and (iii) 500,000 shares are based upon contract performance milestones in 2019 and 2020, earned on a sliding scale, in the event that Fullstack obtains between 4 and 8 new university contracts. The fair value of the performance based Fullstack Contingent Consideration arrangements was estimated by applying a Monte Carlo simulation, based upon the result of forecast information. These measures are based upon significant inputs that are not observable by the market, and are therefore deemed to be Level 3 inputs. At each subsequent reporting date, the Company will remeasure the contingent consideration and recognize any changes in value, if necessary. If the probability of achieving the performance target significantly changes from what was initially anticipated, the change could have a significant impact on the Company’s financial statements in the period recognized. | [
{
"currency_/_unit": "shares",
"end_character": 165,
"end_date_for_period": "2019-04-01",
"label": "eps",
"start_character": 156,
"start_date_for_period": "2019-04-01",
"value": 2250000
},
{
"currency_/_unit": "shares",
"end_character": 187,
"end_date_for_period": "2019-04-01",
"label": "eps",
"start_character": 178,
"start_date_for_period": "2019-04-01",
"value": 1250000
},
{
"currency_/_unit": "shares",
"end_character": 346,
"end_date_for_period": "2019-04-01",
"label": "eps",
"start_character": 339,
"start_date_for_period": "2019-04-01",
"value": 500000
},
{
"currency_/_unit": "USD",
"end_character": 496,
"end_date_for_period": "2019-04-01",
"label": "XBRL-OOS",
"start_character": 492,
"start_date_for_period": "2019-04-01",
"value": 25000000
},
{
"currency_/_unit": "USD",
"end_character": 514,
"end_date_for_period": "2019-04-01",
"label": "XBRL-OOS",
"start_character": 510,
"start_date_for_period": "2019-04-01",
"value": 35000000
},
{
"currency_/_unit": "shares",
"end_character": 541,
"end_date_for_period": "2019-04-01",
"label": "eps",
"start_character": 534,
"start_date_for_period": "2019-04-01",
"value": 500000
},
{
"currency_/_unit": "zvo:university_contract",
"end_character": 686,
"end_date_for_period": "2019-04-01",
"label": "XBRL-OOS",
"start_character": 685,
"start_date_for_period": "2019-04-01",
"value": 4
},
{
"currency_/_unit": "zvo:university_contract",
"end_character": 692,
"end_date_for_period": "2019-04-01",
"label": "XBRL-OOS",
"start_character": 691,
"start_date_for_period": "2019-04-01",
"value": 8
}
] |
10-Q | 0001305323-20-000036 | 20200429161935 | 20200331 | Zovio Inc | The assets and liabilities of TutorMe were recorded on the Company’s condensed consolidated balance sheets at their preliminary estimated fair values as of April 3, 2019, the acquisition date. TutorMe’s results of operations are included in the Company’s condensed consolidated statements of income (loss) from that date. TutorMe recognized revenue of $0.4 million, had an operating loss of $0.8 million, and net loss of $0.8 million for the three months ended March 31, 2020. The Company accounts for business combinations using the acquisition method of accounting. | [
{
"currency_/_unit": "USD",
"end_character": 356,
"end_date_for_period": "2020-03-31",
"label": "revenues",
"start_character": 353,
"start_date_for_period": "2020-01-01",
"value": 400000
},
{
"currency_/_unit": "USD",
"end_character": 395,
"end_date_for_period": "2020-03-31",
"label": "ebit",
"start_character": 392,
"start_date_for_period": "2020-01-01",
"value": 800000
},
{
"currency_/_unit": "USD",
"end_character": 425,
"end_date_for_period": "2020-03-31",
"label": "ebit",
"start_character": 422,
"start_date_for_period": "2020-01-01",
"value": 800000
}
] |
10-Q | 0000203527-20-000015 | 20200512164908 | 20200403 | VARIAN MEDICAL SYSTEMS INC | The Company recorded income of $2.1 million and $4.2 million during the three and six months ended March 29, 2019, respectively, on these equipment leases. | [
{
"currency_/_unit": "USD",
"end_character": 35,
"end_date_for_period": "2019-03-29",
"label": "revenues",
"start_character": 32,
"start_date_for_period": "2018-12-29",
"value": 2100000
},
{
"currency_/_unit": "USD",
"end_character": 52,
"end_date_for_period": "2019-03-29",
"label": "revenues",
"start_character": 49,
"start_date_for_period": "2018-09-29",
"value": 4200000
}
] |
10-Q | 0001546380-20-000019 | 20200506163052 | 20200328 | SCOTTS MIRACLE-GRO CO | U.S. Consumer Segment Profit was $372.9 million in the second quarter of fiscal 2020, an increase of 16.5% from the second quarter of fiscal 2019 Segment Profit of $320.0 million; and was $331.5 million for the first six months of fiscal 2020, an increase of 19.7% from the first six months of fiscal 2019 Segment Profit of $277.0 million. For the three and six months ended March 28, 2020, the increase was due to higher net sales and gross profit rate, partially offset by higher SG&A. | [
{
"currency_/_unit": "USD",
"end_character": 39,
"end_date_for_period": "2020-03-28",
"label": "earnings",
"start_character": 34,
"start_date_for_period": "2019-12-29",
"value": 372900000
},
{
"currency_/_unit": "USD",
"end_character": 170,
"end_date_for_period": "2019-03-30",
"label": "earnings",
"start_character": 165,
"start_date_for_period": "2018-12-30",
"value": 320000000
},
{
"currency_/_unit": "USD",
"end_character": 194,
"end_date_for_period": "2020-03-28",
"label": "earnings",
"start_character": 189,
"start_date_for_period": "2019-10-01",
"value": 331500000
},
{
"currency_/_unit": "USD",
"end_character": 330,
"end_date_for_period": "2019-03-30",
"label": "earnings",
"start_character": 325,
"start_date_for_period": "2018-10-01",
"value": 277000000
}
] |
10-Q | 0001546380-20-000019 | 20200506163052 | 20200328 | SCOTTS MIRACLE-GRO CO | Hawthorne Segment Profit was $25.5 million in the second quarter of fiscal 2020, an increase of 147.6% from the second quarter of fiscal 2019 Segment Profit of $10.3 million; and was $39.4 million for the first six months of fiscal 2020, an increase of 168.0% from the first six months of fiscal 2019 Segment Profit of $14.7 million. For the three and six months ended March 28, 2020, the increase was driven by higher net sales and gross profit rate, partially offset by higher SG&A. | [
{
"currency_/_unit": "USD",
"end_character": 34,
"end_date_for_period": "2020-03-28",
"label": "earnings",
"start_character": 30,
"start_date_for_period": "2019-12-29",
"value": 25500000
},
{
"currency_/_unit": "USD",
"end_character": 165,
"end_date_for_period": "2019-03-30",
"label": "earnings",
"start_character": 161,
"start_date_for_period": "2018-12-30",
"value": 10300000
},
{
"currency_/_unit": "USD",
"end_character": 188,
"end_date_for_period": "2020-03-28",
"label": "earnings",
"start_character": 184,
"start_date_for_period": "2019-10-01",
"value": 39400000
},
{
"currency_/_unit": "USD",
"end_character": 324,
"end_date_for_period": "2019-03-30",
"label": "earnings",
"start_character": 320,
"start_date_for_period": "2018-10-01",
"value": 14700000
}
] |
10-Q | 0001546380-20-000019 | 20200506163052 | 20200328 | SCOTTS MIRACLE-GRO CO | Other Segment Profit was $4.0 million in the second quarter of fiscal 2020, an increase of 5.3% from second quarter of fiscal 2019 Segment Profit of $3.8 million. Other Segment Profit was $0.4 million for the first six months of fiscal 2020, as compared to the first six months of fiscal 2019 Segment Loss of $0.2 million. For the three and six months ended March 28, 2020, the increase was driven by a higher gross profit rate and lower SG&A. | [
{
"currency_/_unit": "USD",
"end_character": 29,
"end_date_for_period": "2020-03-28",
"label": "earnings",
"start_character": 26,
"start_date_for_period": "2019-12-29",
"value": 4000000
},
{
"currency_/_unit": "USD",
"end_character": 153,
"end_date_for_period": "2019-03-30",
"label": "earnings",
"start_character": 150,
"start_date_for_period": "2018-12-30",
"value": 3800000
},
{
"currency_/_unit": "USD",
"end_character": 192,
"end_date_for_period": "2020-03-28",
"label": "earnings",
"start_character": 189,
"start_date_for_period": "2019-10-01",
"value": 400000
},
{
"currency_/_unit": "USD",
"end_character": 313,
"end_date_for_period": "2019-03-30",
"label": "earnings",
"start_character": 310,
"start_date_for_period": "2018-10-01",
"value": -200000
}
] |
10-Q | 0001546380-20-000019 | 20200506163052 | 20200328 | SCOTTS MIRACLE-GRO CO | Corporate expenses were $36.9 million in the second quarter of fiscal 2020, an increase of 7.6% from second quarter of fiscal 2019 expenses of $34.3 million; and were $63.0 million for the first six months of fiscal 2020, an increase of 1.4% from the first six months of fiscal 2019 expenses of $62.1 million. For the three and six months ended March 28, 2020, the increase was driven by higher short-term variable cash incentive compensation expense, partially offset by lower travel expenses. | [
{
"currency_/_unit": "USD",
"end_character": 29,
"end_date_for_period": "2020-03-28",
"label": "earnings",
"start_character": 25,
"start_date_for_period": "2019-12-29",
"value": -36900000
},
{
"currency_/_unit": "USD",
"end_character": 148,
"end_date_for_period": "2019-03-30",
"label": "earnings",
"start_character": 144,
"start_date_for_period": "2018-12-30",
"value": -34300000
},
{
"currency_/_unit": "USD",
"end_character": 172,
"end_date_for_period": "2020-03-28",
"label": "earnings",
"start_character": 168,
"start_date_for_period": "2019-10-01",
"value": -63000000
},
{
"currency_/_unit": "USD",
"end_character": 300,
"end_date_for_period": "2019-03-30",
"label": "earnings",
"start_character": 296,
"start_date_for_period": "2018-10-01",
"value": -62100000
}
] |
10-Q | 0001628280-20-007203 | 20200508155615 | 20200331 | Accelerate Diagnostics, Inc | For the three months ended March 31, 2020, the Company did not carry an income tax provision amount as the Company does not recognize tax benefits from current year tax losses in the U.S. and other foreign jurisdictions. The Company’s tax expense for the three months ended March 31, 2020 differs from the tax expense computed by applying the U.S. statutory tax rate to its year-to-date pre-tax loss of $21.3 million, as no tax benefits were recorded for tax losses generated in the U.S. and other foreign jurisdictions. At March 31, 2020, the Company had deferred tax assets primarily related to U.S. federal and state tax loss carryforwards and a deferred tax liability related to amortization of the Notes. The Company provided a valuation allowance against its net deferred tax assets as future realization of such assets is not more likely than not to occur. | [
{
"currency_/_unit": "USD",
"end_character": 61,
"end_date_for_period": "2020-03-31",
"label": "XBRL-OOS",
"start_character": 59,
"start_date_for_period": "2020-01-01",
"value": 0
},
{
"currency_/_unit": "USD",
"end_character": 409,
"end_date_for_period": "2020-03-31",
"label": "earnings",
"start_character": 405,
"start_date_for_period": "2020-01-01",
"value": -21300000
}
] |
Subsets and Splits